Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mecp2
|
ENSMUSG00000031393.10 | methyl CpG binding protein 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_74085086_74085553 | Mecp2 | 278 | 0.857983 | 0.56 | 3.1e-06 | Click! |
chrX_74086022_74086400 | Mecp2 | 521 | 0.681085 | 0.41 | 9.8e-04 | Click! |
chrX_74084429_74085003 | Mecp2 | 881 | 0.465397 | 0.37 | 3.4e-03 | Click! |
chrX_74083239_74083652 | Mecp2 | 2152 | 0.205466 | 0.24 | 6.0e-02 | Click! |
chrX_74087045_74087196 | Mecp2 | 1430 | 0.293725 | -0.24 | 6.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_35155941_35156382 | 10.76 |
Adcy5 |
adenylate cyclase 5 |
1284 |
0.52 |
chr11_118247336_118248523 | 10.41 |
Cyth1 |
cytohesin 1 |
573 |
0.72 |
chr3_93445694_93447755 | 10.26 |
Tchh |
trichohyalin |
4394 |
0.1 |
chr7_127614503_127615194 | 9.95 |
Zfp629 |
zinc finger protein 629 |
19 |
0.94 |
chr17_88440763_88441485 | 9.88 |
Foxn2 |
forkhead box N2 |
349 |
0.88 |
chr10_81481482_81482676 | 9.88 |
Celf5 |
CUGBP, Elav-like family member 5 |
593 |
0.47 |
chr5_115506738_115507941 | 9.68 |
Pxn |
paxillin |
483 |
0.61 |
chr11_102393440_102394677 | 9.06 |
Rundc3a |
RUN domain containing 3A |
655 |
0.52 |
chr17_34592303_34593396 | 8.97 |
Pbx2 |
pre B cell leukemia homeobox 2 |
115 |
0.87 |
chr11_8467641_8469015 | 8.91 |
Tns3 |
tensin 3 |
347 |
0.93 |
chr10_61382487_61383830 | 8.84 |
Pald1 |
phosphatase domain containing, paladin 1 |
372 |
0.77 |
chr16_35154872_35155809 | 8.67 |
Adcy5 |
adenylate cyclase 5 |
463 |
0.85 |
chr6_48444679_48445729 | 8.67 |
Zfp467 |
zinc finger protein 467 |
114 |
0.93 |
chr14_70554181_70555469 | 8.63 |
Hr |
lysine demethylase and nuclear receptor corepressor |
769 |
0.47 |
chr17_37046004_37046987 | 8.54 |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
73 |
0.94 |
chr1_55405879_55407022 | 8.52 |
Plcl1 |
phospholipase C-like 1 |
529 |
0.71 |
chr9_44287257_44288643 | 8.44 |
Abcg4 |
ATP binding cassette subfamily G member 4 |
188 |
0.83 |
chr15_8444795_8445295 | 8.30 |
Nipbl |
NIPBL cohesin loading factor |
582 |
0.73 |
chr9_23223383_23223854 | 8.26 |
Bmper |
BMP-binding endothelial regulator |
332 |
0.94 |
chr2_116975210_116976309 | 8.18 |
Gm29340 |
predicted gene 29340 |
669 |
0.7 |
chr1_87214020_87214435 | 8.14 |
Eif4e2 |
eukaryotic translation initiation factor 4E member 2 |
59 |
0.95 |
chr11_68399496_68400824 | 7.96 |
Ntn1 |
netrin 1 |
663 |
0.74 |
chr14_20707536_20708243 | 7.95 |
Zswim8 |
zinc finger SWIM-type containing 8 |
18 |
0.94 |
chr8_113635587_113636301 | 7.85 |
Mon1b |
MON1 homolog B, secretory traffciking associated |
109 |
0.96 |
chr10_52690549_52691660 | 7.83 |
Slc35f1 |
solute carrier family 35, member F1 |
571 |
0.73 |
chrX_101301762_101302890 | 7.76 |
Nlgn3 |
neuroligin 3 |
1852 |
0.2 |
chr7_16944715_16945918 | 7.67 |
Pnmal2 |
PNMA-like 2 |
634 |
0.52 |
chr10_61146153_61147577 | 7.66 |
Sgpl1 |
sphingosine phosphate lyase 1 |
33 |
0.97 |
chrX_152144254_152145242 | 7.63 |
Iqsec2 |
IQ motif and Sec7 domain 2 |
476 |
0.81 |
chr19_47463337_47464611 | 7.61 |
Sh3pxd2a |
SH3 and PX domains 2A |
273 |
0.92 |
chr4_129985171_129986191 | 7.60 |
Adgrb2 |
adhesion G protein-coupled receptor B2 |
413 |
0.79 |
chr9_42944563_42944876 | 7.58 |
Grik4 |
glutamate receptor, ionotropic, kainate 4 |
226 |
0.91 |
chr18_15063047_15063264 | 7.49 |
Kctd1 |
potassium channel tetramerisation domain containing 1 |
463 |
0.85 |
chr12_78226756_78227482 | 7.49 |
Gphn |
gephyrin |
466 |
0.52 |
chr1_121431152_121432202 | 7.49 |
Ccdc93 |
coiled-coil domain containing 93 |
567 |
0.76 |
chr1_75479594_75480098 | 7.48 |
Tmem198 |
transmembrane protein 198 |
142 |
0.8 |
chr8_25601540_25602044 | 7.42 |
Nsd3 |
nuclear receptor binding SET domain protein 3 |
191 |
0.88 |
chr10_81559537_81560658 | 7.41 |
Tle5 |
TLE family member 5, transcriptional modulator |
603 |
0.48 |
chr1_10232057_10233001 | 7.41 |
Arfgef1 |
ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited) |
141 |
0.97 |
chr11_94472657_94474433 | 7.40 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
96 |
0.95 |
chr9_110531844_110532290 | 7.37 |
Setd2 |
SET domain containing 2 |
530 |
0.71 |
chr15_96286337_96286712 | 7.31 |
Arid2 |
AT rich interactive domain 2 (ARID, RFX-like) |
994 |
0.5 |
chr11_76026926_76027744 | 7.31 |
Rflnb |
refilin B |
447 |
0.83 |
chr4_134496639_134497966 | 7.25 |
Paqr7 |
progestin and adipoQ receptor family member VII |
261 |
0.84 |
chr11_98836833_98837736 | 7.20 |
Rapgefl1 |
Rap guanine nucleotide exchange factor (GEF)-like 1 |
499 |
0.65 |
chr1_132880197_132881455 | 7.18 |
Lrrn2 |
leucine rich repeat protein 2, neuronal |
471 |
0.81 |
chr17_47877478_47879368 | 7.17 |
Foxp4 |
forkhead box P4 |
530 |
0.7 |
chr1_39900364_39900755 | 7.13 |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
354 |
0.9 |
chr7_44310203_44311401 | 7.10 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
549 |
0.46 |
chr16_3744141_3745052 | 7.10 |
Zfp263 |
zinc finger protein 263 |
1 |
0.96 |
chr16_55894668_55895780 | 7.08 |
Nxpe3 |
neurexophilin and PC-esterase domain family, member 3 |
61 |
0.96 |
chr4_139192993_139194155 | 7.08 |
Capzb |
capping protein (actin filament) muscle Z-line, beta |
422 |
0.8 |
chr7_4119233_4120703 | 7.07 |
Ttyh1 |
tweety family member 1 |
214 |
0.7 |
chr8_95331014_95331789 | 7.05 |
Zfp319 |
zinc finger protein 319 |
549 |
0.53 |
chr17_46297885_46298712 | 7.04 |
Dlk2 |
delta like non-canonical Notch ligand 2 |
215 |
0.88 |
chr16_18348211_18349024 | 7.04 |
Arvcf |
armadillo repeat gene deleted in velocardiofacial syndrome |
343 |
0.56 |
chr19_6497246_6498663 | 6.98 |
Nrxn2 |
neurexin II |
119 |
0.94 |
chr15_78717784_78718525 | 6.97 |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
41 |
0.97 |
chr16_37868071_37868278 | 6.97 |
Lrrc58 |
leucine rich repeat containing 58 |
215 |
0.91 |
chr7_19082814_19086200 | 6.96 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr1_181352684_181353876 | 6.94 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
82 |
0.97 |
chr1_119526084_119526715 | 6.92 |
Gm27184 |
predicted gene 27184 |
40 |
0.73 |
chr8_40511841_40512420 | 6.88 |
Vps37a |
vacuolar protein sorting 37A |
262 |
0.61 |
chr5_147430675_147431296 | 6.87 |
Pan3 |
PAN3 poly(A) specific ribonuclease subunit |
89 |
0.93 |
chr1_52726408_52727595 | 6.86 |
Mfsd6 |
major facilitator superfamily domain containing 6 |
357 |
0.85 |
chr3_63295316_63296270 | 6.85 |
Mme |
membrane metallo endopeptidase |
79 |
0.98 |
chr9_121760074_121760590 | 6.82 |
Zfp651 |
zinc finger protein 651 |
299 |
0.53 |
chr11_83440563_83441186 | 6.82 |
1700020L24Rik |
RIKEN cDNA 1700020L24 gene |
743 |
0.51 |
chr15_97766466_97767934 | 6.81 |
Rapgef3 |
Rap guanine nucleotide exchange factor (GEF) 3 |
64 |
0.91 |
chr10_70244802_70245858 | 6.81 |
Slc16a9 |
solute carrier family 16 (monocarboxylic acid transporters), member 9 |
230 |
0.93 |
chr15_85653123_85654040 | 6.80 |
Lncppara |
long noncoding RNA near Ppara |
35 |
0.97 |
chr6_122819948_122820699 | 6.73 |
Foxj2 |
forkhead box J2 |
188 |
0.6 |
chr3_57846934_57847478 | 6.72 |
Pfn2 |
profilin 2 |
61 |
0.97 |
chr17_78834857_78835300 | 6.72 |
Heatr5b |
HEAT repeat containing 5B |
246 |
0.69 |
chr8_66860259_66861065 | 6.71 |
Naf1 |
nuclear assembly factor 1 ribonucleoprotein |
295 |
0.9 |
chr7_62376325_62378263 | 6.70 |
Magel2 |
melanoma antigen, family L, 2 |
284 |
0.9 |
chr5_130448513_130449808 | 6.68 |
Caln1 |
calneuron 1 |
359 |
0.91 |
chr14_20661277_20662439 | 6.67 |
Synpo2l |
synaptopodin 2-like |
2716 |
0.12 |
chr11_77982951_77984470 | 6.67 |
Phf12 |
PHD finger protein 12 |
908 |
0.44 |
chrX_73672828_73674470 | 6.66 |
Slc6a8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
58 |
0.96 |
chr11_78188780_78189591 | 6.66 |
Rab34 |
RAB34, member RAS oncogene family |
55 |
0.91 |
chr5_135777784_135778296 | 6.65 |
Styxl1 |
serine/threonine/tyrosine interacting-like 1 |
198 |
0.71 |
chr13_13783848_13785188 | 6.64 |
Gng4 |
guanine nucleotide binding protein (G protein), gamma 4 |
189 |
0.94 |
chr16_55973886_55974955 | 6.63 |
Zbtb11os1 |
zinc finger and BTB domain containing 11, opposite strand 1 |
197 |
0.76 |
chr2_156613822_156614400 | 6.62 |
Dlgap4 |
DLG associated protein 4 |
406 |
0.56 |
chr1_95313687_95314478 | 6.61 |
Fam174a |
family with sequence similarity 174, member A |
454 |
0.85 |
chr5_69340481_69341683 | 6.59 |
Gm24368 |
predicted gene, 24368 |
299 |
0.7 |
chr5_98253766_98254950 | 6.58 |
Fgf5 |
fibroblast growth factor 5 |
54 |
0.98 |
chr7_79148061_79149306 | 6.56 |
Mfge8 |
milk fat globule-EGF factor 8 protein |
306 |
0.89 |
chr5_103753891_103754472 | 6.55 |
Aff1 |
AF4/FMR2 family, member 1 |
19 |
0.98 |
chr11_76945396_76946485 | 6.51 |
Blmh |
bleomycin hydrolase |
89 |
0.96 |
chr10_8517718_8519118 | 6.51 |
Ust |
uronyl-2-sulfotransferase |
407 |
0.91 |
chr15_85645713_85647012 | 6.50 |
Gm49539 |
predicted gene, 49539 |
279 |
0.89 |
chr3_108414928_108416069 | 6.49 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
54 |
0.94 |
chr8_106415381_106416468 | 6.48 |
Zfp90 |
zinc finger protein 90 |
525 |
0.8 |
chr1_143777327_143778147 | 6.45 |
Gm29170 |
predicted gene 29170 |
95 |
0.77 |
chr3_127836757_127837425 | 6.44 |
Ap1ar |
adaptor-related protein complex 1 associated regulatory protein |
140 |
0.54 |
chr16_44557565_44558882 | 6.43 |
Mir3081 |
microRNA 3081 |
94 |
0.92 |
chr5_135393862_135394505 | 6.41 |
Pom121 |
nuclear pore membrane protein 121 |
363 |
0.8 |
chr13_55210348_55211522 | 6.37 |
Nsd1 |
nuclear receptor-binding SET-domain protein 1 |
200 |
0.92 |
chr11_106085045_106085655 | 6.37 |
Map3k3 |
mitogen-activated protein kinase kinase kinase 3 |
737 |
0.5 |
chr8_64692512_64692994 | 6.36 |
Cpe |
carboxypeptidase E |
301 |
0.89 |
chr11_95824535_95825258 | 6.35 |
Phospho1 |
phosphatase, orphan 1 |
396 |
0.75 |
chr13_43302909_43304148 | 6.35 |
Gfod1 |
glucose-fructose oxidoreductase domain containing 1 |
123 |
0.97 |
chr11_106271676_106273001 | 6.34 |
Smarcd2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
627 |
0.51 |
chr8_106870248_106871632 | 6.33 |
Has3 |
hyaluronan synthase 3 |
49 |
0.97 |
chr4_136835995_136836775 | 6.32 |
Ephb2 |
Eph receptor B2 |
397 |
0.85 |
chr1_17096620_17097786 | 6.31 |
Jph1 |
junctophilin 1 |
686 |
0.71 |
chr3_100686047_100686231 | 6.31 |
Man1a2 |
mannosidase, alpha, class 1A, member 2 |
636 |
0.62 |
chr10_43479310_43479828 | 6.31 |
Bend3 |
BEN domain containing 3 |
429 |
0.77 |
chr11_69415057_69416220 | 6.31 |
Kdm6b |
KDM1 lysine (K)-specific demethylase 6B |
1963 |
0.16 |
chr7_100893244_100895336 | 6.29 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
400 |
0.8 |
chr5_118169234_118170295 | 6.28 |
Hrk |
harakiri, BCL2 interacting protein (contains only BH3 domain) |
16 |
0.97 |
chr6_94283405_94283886 | 6.27 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
250 |
0.94 |
chr15_100871055_100872065 | 6.26 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
140 |
0.96 |
chr9_58487884_58489303 | 6.24 |
Insyn1 |
inhibitory synaptic factor 1 |
10 |
0.98 |
chr14_11553579_11554605 | 6.23 |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
511 |
0.82 |
chr10_123196235_123196909 | 6.23 |
Gm4129 |
predicted gene 4129 |
123 |
0.66 |
chr15_102355454_102356344 | 6.23 |
Gm36246 |
predicted gene, 36246 |
5072 |
0.09 |
chr1_178529912_178530655 | 6.20 |
Kif26b |
kinesin family member 26B |
1158 |
0.57 |
chr14_34819835_34820684 | 6.18 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
151 |
0.96 |
chr6_18514208_18514525 | 6.17 |
Cttnbp2 |
cortactin binding protein 2 |
383 |
0.89 |
chr5_108366794_108367648 | 6.16 |
Gm10419 |
predicted gene 10419 |
548 |
0.44 |
chr8_44938214_44938962 | 6.16 |
Fat1 |
FAT atypical cadherin 1 |
3141 |
0.25 |
chr19_58860202_58860974 | 6.14 |
Hspa12a |
heat shock protein 12A |
50 |
0.98 |
chr9_69289938_69290878 | 6.14 |
Rora |
RAR-related orphan receptor alpha |
726 |
0.75 |
chr15_86028772_86030702 | 6.12 |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
4466 |
0.22 |
chr11_102295635_102296368 | 6.12 |
Atxn7l3 |
ataxin 7-like 3 |
628 |
0.55 |
chr17_63864037_63864741 | 6.11 |
Fer |
fer (fms/fps related) protein kinase |
374 |
0.65 |
chr15_100761780_100762542 | 6.11 |
Slc4a8 |
solute carrier family 4 (anion exchanger), member 8 |
273 |
0.88 |
chr13_14063842_14064362 | 6.11 |
Arid4b |
AT rich interactive domain 4B (RBP1-like) |
47 |
0.91 |
chr6_125312691_125314238 | 6.07 |
Ltbr |
lymphotoxin B receptor |
199 |
0.88 |
chr6_42349189_42350019 | 6.07 |
Zyx |
zyxin |
26 |
0.93 |
chr14_55540008_55541283 | 6.05 |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
178 |
0.82 |
chr9_20868528_20869547 | 6.05 |
Shfl |
shiftless antiviral inhibitor of ribosomal frameshifting |
240 |
0.82 |
chr13_119755599_119756427 | 6.04 |
Gm41077 |
predicted gene, 41077 |
80 |
0.56 |
chr1_92849002_92850443 | 6.02 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr18_11839902_11840416 | 6.01 |
Mir1901 |
microRNA 1901 |
279 |
0.7 |
chr1_181212046_181212413 | 5.99 |
Wdr26 |
WD repeat domain 26 |
228 |
0.91 |
chr14_65952886_65954310 | 5.99 |
Scara3 |
scavenger receptor class A, member 3 |
337 |
0.86 |
chr9_71771338_71771854 | 5.99 |
Cgnl1 |
cingulin-like 1 |
6 |
0.98 |
chrX_56731988_56732298 | 5.98 |
Fhl1 |
four and a half LIM domains 1 |
14 |
0.97 |
chr4_106315796_106316221 | 5.98 |
Usp24 |
ubiquitin specific peptidase 24 |
205 |
0.93 |
chr7_28277767_28278289 | 5.98 |
Eid2b |
EP300 interacting inhibitor of differentiation 2B |
289 |
0.78 |
chr10_79916706_79917340 | 5.98 |
R3hdm4 |
R3H domain containing 4 |
17 |
0.5 |
chr8_69808374_69809438 | 5.97 |
Gmip |
Gem-interacting protein |
216 |
0.87 |
chr7_99381585_99382385 | 5.97 |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
571 |
0.71 |
chr9_56864653_56866648 | 5.97 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
617 |
0.51 |
chr13_56134633_56135841 | 5.97 |
Macroh2a1 |
macroH2A.1 histone |
203 |
0.93 |
chr11_3912723_3914665 | 5.95 |
Slc35e4 |
solute carrier family 35, member E4 |
970 |
0.37 |
chr10_77417244_77418210 | 5.95 |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
127 |
0.96 |
chr13_54765549_54766801 | 5.95 |
Sncb |
synuclein, beta |
78 |
0.95 |
chr1_23761798_23762867 | 5.93 |
B3gat2 |
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
321 |
0.93 |
chr9_45838599_45839713 | 5.93 |
Bace1 |
beta-site APP cleaving enzyme 1 |
84 |
0.93 |
chr2_4717476_4717767 | 5.92 |
Bend7 |
BEN domain containing 7 |
210 |
0.94 |
chr15_75746536_75747326 | 5.92 |
Mafa |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) |
1297 |
0.33 |
chr5_98030089_98031247 | 5.89 |
Antxr2 |
anthrax toxin receptor 2 |
294 |
0.79 |
chr7_84409381_84409909 | 5.88 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
238 |
0.92 |
chr6_147091310_147092432 | 5.87 |
Klhl42 |
kelch-like 42 |
492 |
0.74 |
chr4_149518140_149519087 | 5.86 |
Ctnnbip1 |
catenin beta interacting protein 1 |
377 |
0.7 |
chrX_42149485_42150374 | 5.86 |
Stag2 |
stromal antigen 2 |
225 |
0.52 |
chr10_76344682_76345285 | 5.86 |
Dip2a |
disco interacting protein 2 homolog A |
249 |
0.89 |
chr8_75213209_75214064 | 5.84 |
Rasd2 |
RASD family, member 2 |
308 |
0.88 |
chr9_59036710_59037270 | 5.84 |
Neo1 |
neogenin |
549 |
0.83 |
chr4_152096248_152097724 | 5.83 |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
267 |
0.86 |
chr5_138263328_138264013 | 5.82 |
Map11 |
microtubule associated protein 11 |
320 |
0.46 |
chr11_120347791_120348417 | 5.81 |
Actg1 |
actin, gamma, cytoplasmic 1 |
13 |
0.85 |
chr7_127207221_127208502 | 5.81 |
Tbc1d10b |
TBC1 domain family, member 10b |
114 |
0.88 |
chr7_29303968_29305229 | 5.81 |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
622 |
0.58 |
chr2_64098382_64098920 | 5.80 |
Fign |
fidgetin |
613 |
0.85 |
chr14_103650211_103650540 | 5.80 |
Slain1 |
SLAIN motif family, member 1 |
147 |
0.55 |
chr19_57611036_57611812 | 5.80 |
Atrnl1 |
attractin like 1 |
390 |
0.86 |
chr10_81426043_81427197 | 5.80 |
Nfic |
nuclear factor I/C |
494 |
0.54 |
chr7_127746262_127747476 | 5.80 |
Fbxl19 |
F-box and leucine-rich repeat protein 19 |
94 |
0.92 |
chrX_74022966_74023767 | 5.77 |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
10 |
0.71 |
chr2_165325872_165326486 | 5.75 |
Elmo2 |
engulfment and cell motility 2 |
300 |
0.87 |
chr10_121310005_121311316 | 5.74 |
Tbc1d30 |
TBC1 domain family, member 30 |
529 |
0.73 |
chr2_120977066_120978028 | 5.73 |
Tmem62 |
transmembrane protein 62 |
14 |
0.69 |
chr11_83409236_83410456 | 5.72 |
Rasl10b |
RAS-like, family 10, member B |
158 |
0.92 |
chr4_141444731_141445089 | 5.72 |
Zbtb17 |
zinc finger and BTB domain containing 17 |
204 |
0.89 |
chr11_116105976_116108472 | 5.70 |
Trim47 |
tripartite motif-containing 47 |
141 |
0.91 |
chr14_70520073_70520646 | 5.70 |
Bmp1 |
bone morphogenetic protein 1 |
125 |
0.92 |
chr7_78846764_78847217 | 5.70 |
1700011D18Rik |
RIKEN cDNA 1700011D18 gene |
264 |
0.48 |
chr16_76373206_76373751 | 5.70 |
Nrip1 |
nuclear receptor interacting protein 1 |
348 |
0.88 |
chr6_63256981_63257723 | 5.70 |
9330118I20Rik |
RIKEN cDNA 9330118I20 gene |
273 |
0.71 |
chr9_67047833_67050057 | 5.70 |
Tpm1 |
tropomyosin 1, alpha |
173 |
0.95 |
chr7_93079849_93081191 | 5.69 |
Gm9934 |
predicted gene 9934 |
274 |
0.76 |
chr9_54699536_54700344 | 5.69 |
Dnaja4 |
DnaJ heat shock protein family (Hsp40) member A4 |
381 |
0.8 |
chr11_61854068_61855004 | 5.67 |
Ulk2 |
unc-51 like kinase 2 |
34 |
0.97 |
chr1_173366699_173367980 | 5.66 |
Cadm3 |
cell adhesion molecule 3 |
294 |
0.89 |
chr8_105693426_105694998 | 5.66 |
Carmil2 |
capping protein regulator and myosin 1 linker 2 |
852 |
0.36 |
chr2_158667198_158668458 | 5.65 |
Ppp1r16b |
protein phosphatase 1, regulatory subunit 16B |
709 |
0.61 |
chr2_164833833_164834511 | 5.64 |
Ctsa |
cathepsin A |
99 |
0.87 |
chr1_23382572_23383092 | 5.64 |
Ogfrl1 |
opioid growth factor receptor-like 1 |
343 |
0.88 |
chr4_130308360_130309581 | 5.63 |
Gm10570 |
predicted gene 10570 |
296 |
0.55 |
chr7_45872838_45873965 | 5.62 |
Kdelr1 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
274 |
0.76 |
chr8_84770692_84772567 | 5.62 |
Nfix |
nuclear factor I/X |
1767 |
0.22 |
chr7_49247685_49248635 | 5.61 |
Nav2 |
neuron navigator 2 |
1315 |
0.51 |
chr18_50128247_50129033 | 5.61 |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
146 |
0.96 |
chr9_45430098_45431532 | 5.60 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
417 |
0.52 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 6.6 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
5.4 | 16.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
5.3 | 5.3 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
5.2 | 5.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
5.2 | 15.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
4.8 | 19.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
4.6 | 4.6 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
4.6 | 50.7 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
4.6 | 4.6 | GO:0097581 | lamellipodium organization(GO:0097581) |
4.5 | 18.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
4.5 | 13.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
4.3 | 17.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
4.3 | 25.9 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
4.3 | 12.9 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
4.1 | 4.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
4.1 | 24.9 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
4.1 | 4.1 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
4.0 | 15.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
3.9 | 15.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
3.9 | 3.9 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
3.8 | 7.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
3.8 | 7.5 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
3.7 | 11.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
3.7 | 11.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
3.7 | 11.1 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
3.7 | 25.8 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
3.7 | 11.0 | GO:1903375 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
3.7 | 11.0 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
3.7 | 32.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
3.6 | 10.8 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
3.6 | 14.2 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
3.5 | 10.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
3.5 | 10.4 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
3.5 | 10.4 | GO:0007525 | somatic muscle development(GO:0007525) |
3.4 | 10.3 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
3.4 | 13.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
3.4 | 6.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
3.3 | 6.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
3.3 | 22.8 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
3.3 | 9.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.3 | 13.0 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
3.3 | 9.8 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
3.2 | 6.4 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
3.2 | 9.6 | GO:1903416 | response to glycoside(GO:1903416) |
3.2 | 19.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
3.1 | 6.3 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
3.1 | 12.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
3.1 | 6.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.0 | 6.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
3.0 | 3.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
3.0 | 9.1 | GO:0021586 | pons maturation(GO:0021586) |
3.0 | 6.0 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
3.0 | 35.8 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
3.0 | 32.8 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
3.0 | 20.8 | GO:1901660 | calcium ion export(GO:1901660) |
3.0 | 3.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
2.9 | 23.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.9 | 2.9 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
2.9 | 8.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
2.9 | 5.9 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.9 | 2.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.9 | 11.6 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
2.9 | 8.7 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
2.9 | 14.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
2.9 | 8.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
2.9 | 8.6 | GO:0036166 | phenotypic switching(GO:0036166) |
2.8 | 8.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
2.8 | 8.5 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
2.8 | 14.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
2.8 | 8.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
2.8 | 8.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.8 | 8.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.8 | 13.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
2.7 | 5.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
2.7 | 8.2 | GO:0030242 | pexophagy(GO:0030242) |
2.7 | 2.7 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
2.7 | 2.7 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
2.7 | 8.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
2.7 | 2.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.7 | 10.9 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
2.7 | 5.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
2.7 | 2.7 | GO:1902065 | response to L-glutamate(GO:1902065) |
2.7 | 5.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
2.7 | 5.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.7 | 2.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
2.6 | 2.6 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
2.6 | 5.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.6 | 10.5 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
2.6 | 10.5 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
2.6 | 10.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
2.6 | 20.8 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
2.6 | 2.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.6 | 7.8 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
2.6 | 2.6 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
2.6 | 18.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.6 | 7.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.6 | 7.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
2.6 | 10.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
2.5 | 17.7 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
2.5 | 7.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.5 | 7.5 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
2.5 | 7.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
2.5 | 27.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
2.5 | 12.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
2.5 | 12.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
2.5 | 9.9 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
2.5 | 9.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.5 | 7.4 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
2.5 | 12.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
2.5 | 7.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
2.5 | 7.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
2.5 | 2.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.5 | 4.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
2.5 | 7.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
2.4 | 9.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
2.4 | 12.2 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
2.4 | 4.9 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
2.4 | 7.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
2.4 | 29.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
2.4 | 16.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.4 | 7.2 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
2.4 | 14.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.4 | 2.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
2.4 | 7.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
2.4 | 21.6 | GO:0071625 | vocalization behavior(GO:0071625) |
2.4 | 16.7 | GO:0051775 | response to redox state(GO:0051775) |
2.4 | 2.4 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
2.4 | 7.1 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
2.4 | 2.4 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
2.4 | 9.5 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
2.4 | 4.7 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
2.4 | 7.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.3 | 7.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
2.3 | 4.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.3 | 7.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
2.3 | 13.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
2.3 | 13.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
2.3 | 27.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
2.3 | 6.9 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
2.3 | 6.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
2.3 | 4.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
2.3 | 2.3 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
2.3 | 9.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
2.3 | 2.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.3 | 11.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
2.3 | 2.3 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.2 | 15.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
2.2 | 4.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
2.2 | 2.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
2.2 | 2.2 | GO:0010039 | response to iron ion(GO:0010039) |
2.2 | 17.9 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
2.2 | 8.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.2 | 6.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
2.2 | 13.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
2.2 | 2.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.2 | 6.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
2.2 | 15.5 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
2.2 | 15.5 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
2.2 | 6.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
2.2 | 4.4 | GO:1905049 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
2.2 | 8.8 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
2.2 | 2.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.2 | 8.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.2 | 2.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
2.2 | 4.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.2 | 6.6 | GO:0046061 | dATP catabolic process(GO:0046061) |
2.2 | 6.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.2 | 4.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
2.2 | 10.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
2.2 | 8.7 | GO:0061038 | uterus morphogenesis(GO:0061038) |
2.2 | 10.9 | GO:0048102 | autophagic cell death(GO:0048102) |
2.2 | 4.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.2 | 8.7 | GO:0008228 | opsonization(GO:0008228) |
2.2 | 10.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
2.2 | 4.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
2.2 | 30.3 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
2.2 | 13.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
2.2 | 6.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
2.2 | 8.6 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
2.2 | 15.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
2.2 | 6.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
2.1 | 8.6 | GO:0009838 | abscission(GO:0009838) |
2.1 | 6.4 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
2.1 | 6.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
2.1 | 6.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
2.1 | 6.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
2.1 | 4.3 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
2.1 | 2.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
2.1 | 12.8 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
2.1 | 4.2 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.1 | 6.4 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
2.1 | 4.2 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.1 | 4.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
2.1 | 8.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
2.1 | 4.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
2.1 | 4.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
2.1 | 6.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
2.1 | 4.2 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
2.1 | 4.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
2.1 | 6.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
2.1 | 6.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
2.1 | 2.1 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
2.1 | 20.8 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
2.1 | 6.2 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
2.1 | 2.1 | GO:0048678 | response to axon injury(GO:0048678) |
2.1 | 6.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.1 | 8.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
2.1 | 14.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
2.0 | 10.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
2.0 | 8.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.0 | 12.2 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
2.0 | 6.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
2.0 | 2.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.0 | 6.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
2.0 | 8.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
2.0 | 4.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
2.0 | 6.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.0 | 6.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
2.0 | 6.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
2.0 | 2.0 | GO:0060026 | convergent extension(GO:0060026) |
2.0 | 12.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
2.0 | 2.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
2.0 | 8.0 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
2.0 | 8.0 | GO:0032762 | mast cell cytokine production(GO:0032762) |
2.0 | 4.0 | GO:0033227 | dsRNA transport(GO:0033227) |
2.0 | 2.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
2.0 | 23.8 | GO:0060544 | regulation of necroptotic process(GO:0060544) |
2.0 | 5.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.0 | 7.9 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
2.0 | 17.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
2.0 | 7.8 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
2.0 | 13.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
2.0 | 5.9 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
2.0 | 11.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.9 | 3.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.9 | 3.9 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
1.9 | 3.9 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
1.9 | 3.9 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.9 | 5.8 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
1.9 | 9.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.9 | 9.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
1.9 | 1.9 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.9 | 15.4 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
1.9 | 1.9 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
1.9 | 5.8 | GO:0051182 | coenzyme transport(GO:0051182) |
1.9 | 3.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.9 | 5.8 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.9 | 7.6 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
1.9 | 9.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.9 | 11.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.9 | 7.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.9 | 1.9 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.9 | 11.4 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.9 | 3.8 | GO:0072553 | terminal button organization(GO:0072553) |
1.9 | 9.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
1.9 | 5.7 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.9 | 3.8 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
1.9 | 5.7 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.9 | 5.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.9 | 3.8 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.9 | 11.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.9 | 1.9 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.9 | 9.4 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
1.9 | 7.5 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
1.9 | 14.9 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.9 | 5.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.9 | 3.7 | GO:0046039 | GTP metabolic process(GO:0046039) |
1.9 | 7.4 | GO:0060281 | regulation of oocyte development(GO:0060281) |
1.9 | 3.7 | GO:0048242 | epinephrine secretion(GO:0048242) |
1.8 | 5.5 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
1.8 | 3.7 | GO:1903423 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
1.8 | 3.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.8 | 3.7 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
1.8 | 5.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
1.8 | 7.4 | GO:0046909 | intermembrane transport(GO:0046909) |
1.8 | 14.7 | GO:0010388 | cullin deneddylation(GO:0010388) |
1.8 | 3.7 | GO:0003032 | detection of oxygen(GO:0003032) |
1.8 | 3.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.8 | 9.2 | GO:0046836 | glycolipid transport(GO:0046836) |
1.8 | 1.8 | GO:1903362 | regulation of cellular protein catabolic process(GO:1903362) |
1.8 | 7.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.8 | 7.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
1.8 | 11.0 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
1.8 | 10.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.8 | 9.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
1.8 | 7.3 | GO:0015819 | lysine transport(GO:0015819) |
1.8 | 10.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.8 | 14.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.8 | 27.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
1.8 | 5.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.8 | 3.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.8 | 7.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.8 | 9.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.8 | 1.8 | GO:0008380 | RNA splicing(GO:0008380) |
1.8 | 1.8 | GO:0030421 | defecation(GO:0030421) |
1.8 | 8.9 | GO:0070842 | aggresome assembly(GO:0070842) |
1.8 | 5.4 | GO:0044849 | estrous cycle(GO:0044849) |
1.8 | 5.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.8 | 3.6 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.8 | 7.1 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.8 | 10.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.8 | 5.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
1.8 | 5.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.8 | 3.5 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
1.8 | 1.8 | GO:0009180 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
1.8 | 7.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.8 | 7.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.8 | 5.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.8 | 10.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.7 | 5.2 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.7 | 1.7 | GO:0051409 | response to nitrosative stress(GO:0051409) |
1.7 | 5.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.7 | 5.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
1.7 | 1.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.7 | 5.2 | GO:0019086 | late viral transcription(GO:0019086) |
1.7 | 5.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.7 | 5.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.7 | 10.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
1.7 | 3.4 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
1.7 | 5.1 | GO:0038001 | paracrine signaling(GO:0038001) |
1.7 | 12.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.7 | 3.4 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
1.7 | 1.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.7 | 6.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.7 | 8.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
1.7 | 10.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.7 | 6.8 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.7 | 8.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.7 | 1.7 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
1.7 | 3.4 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
1.7 | 3.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.7 | 20.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
1.7 | 1.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.7 | 10.1 | GO:0016266 | O-glycan processing(GO:0016266) |
1.7 | 6.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.7 | 11.7 | GO:0036315 | cellular response to sterol(GO:0036315) |
1.7 | 3.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.7 | 3.3 | GO:0031223 | auditory behavior(GO:0031223) |
1.7 | 6.7 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
1.7 | 10.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.7 | 21.6 | GO:0045116 | protein neddylation(GO:0045116) |
1.7 | 3.3 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
1.7 | 1.7 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
1.7 | 1.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.7 | 3.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.6 | 3.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
1.6 | 4.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.6 | 6.6 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
1.6 | 4.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.6 | 4.9 | GO:0033762 | response to glucagon(GO:0033762) |
1.6 | 11.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.6 | 8.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.6 | 8.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.6 | 3.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.6 | 1.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
1.6 | 8.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.6 | 3.2 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.6 | 3.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
1.6 | 1.6 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.6 | 4.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
1.6 | 1.6 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.6 | 8.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
1.6 | 4.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.6 | 11.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.6 | 12.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.6 | 4.8 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
1.6 | 16.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.6 | 4.8 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
1.6 | 6.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.6 | 6.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.6 | 22.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
1.6 | 4.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.6 | 35.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.6 | 4.8 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.6 | 8.0 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
1.6 | 1.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.6 | 3.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.6 | 1.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.6 | 7.9 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.6 | 1.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.6 | 6.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.6 | 3.2 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
1.6 | 9.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.6 | 4.7 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
1.6 | 1.6 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.6 | 7.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.6 | 4.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.6 | 4.7 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
1.6 | 18.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.6 | 3.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.6 | 3.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.6 | 4.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.6 | 4.7 | GO:0033058 | directional locomotion(GO:0033058) |
1.6 | 1.6 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.6 | 4.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.6 | 3.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.5 | 9.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.5 | 32.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
1.5 | 1.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.5 | 6.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.5 | 12.3 | GO:0002934 | desmosome organization(GO:0002934) |
1.5 | 4.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.5 | 1.5 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
1.5 | 3.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
1.5 | 7.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.5 | 1.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.5 | 6.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.5 | 9.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.5 | 4.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.5 | 4.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.5 | 1.5 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
1.5 | 3.0 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.5 | 6.1 | GO:0080009 | mRNA methylation(GO:0080009) |
1.5 | 1.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
1.5 | 7.6 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
1.5 | 7.6 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.5 | 3.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.5 | 12.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
1.5 | 21.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.5 | 7.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.5 | 21.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.5 | 3.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.5 | 7.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.5 | 3.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.5 | 7.5 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
1.5 | 7.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.5 | 6.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.5 | 3.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.5 | 10.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.5 | 1.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.5 | 3.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
1.5 | 10.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.5 | 5.9 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
1.5 | 1.5 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
1.5 | 4.4 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
1.5 | 1.5 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.5 | 8.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.5 | 16.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.5 | 2.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.5 | 5.9 | GO:0048478 | replication fork protection(GO:0048478) |
1.5 | 5.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
1.5 | 2.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.5 | 8.8 | GO:0060013 | righting reflex(GO:0060013) |
1.5 | 5.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.5 | 1.5 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.5 | 1.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.5 | 1.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.5 | 2.9 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.4 | 4.3 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.4 | 4.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.4 | 4.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.4 | 11.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
1.4 | 4.3 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.4 | 5.8 | GO:0070459 | prolactin secretion(GO:0070459) |
1.4 | 2.9 | GO:0001302 | replicative cell aging(GO:0001302) |
1.4 | 5.8 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
1.4 | 2.9 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
1.4 | 4.3 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.4 | 1.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.4 | 2.9 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.4 | 1.4 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.4 | 8.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
1.4 | 4.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.4 | 11.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.4 | 2.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.4 | 2.8 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
1.4 | 5.6 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.4 | 15.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.4 | 19.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
1.4 | 1.4 | GO:0022406 | membrane docking(GO:0022406) |
1.4 | 11.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.4 | 7.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.4 | 5.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
1.4 | 8.4 | GO:0015074 | DNA integration(GO:0015074) |
1.4 | 5.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.4 | 14.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.4 | 4.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.4 | 1.4 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
1.4 | 15.3 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
1.4 | 2.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
1.4 | 8.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.4 | 9.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.4 | 4.1 | GO:0033135 | regulation of peptidyl-serine phosphorylation(GO:0033135) |
1.4 | 5.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.4 | 4.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.4 | 6.9 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.4 | 1.4 | GO:0051665 | membrane raft localization(GO:0051665) |
1.4 | 1.4 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
1.4 | 5.5 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.4 | 11.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
1.4 | 2.7 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
1.4 | 5.5 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.4 | 1.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
1.4 | 6.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
1.4 | 1.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.4 | 5.5 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.4 | 2.7 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
1.4 | 5.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.4 | 4.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
1.4 | 8.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.4 | 4.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.4 | 6.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.4 | 9.5 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.4 | 4.1 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.4 | 1.4 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
1.4 | 10.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.4 | 33.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
1.4 | 2.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.3 | 5.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.3 | 9.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.3 | 4.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.3 | 1.3 | GO:1902004 | beta-amyloid formation(GO:0034205) amyloid precursor protein catabolic process(GO:0042987) regulation of beta-amyloid formation(GO:1902003) positive regulation of beta-amyloid formation(GO:1902004) regulation of amyloid precursor protein catabolic process(GO:1902991) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.3 | 4.0 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.3 | 4.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.3 | 1.3 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
1.3 | 1.3 | GO:0045869 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
1.3 | 1.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
1.3 | 30.7 | GO:0006491 | N-glycan processing(GO:0006491) |
1.3 | 4.0 | GO:0006108 | malate metabolic process(GO:0006108) |
1.3 | 5.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.3 | 16.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.3 | 6.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.3 | 4.0 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
1.3 | 1.3 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
1.3 | 2.7 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
1.3 | 5.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
1.3 | 6.6 | GO:0021756 | striatum development(GO:0021756) |
1.3 | 2.6 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.3 | 4.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.3 | 9.2 | GO:0006903 | vesicle targeting(GO:0006903) |
1.3 | 4.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.3 | 14.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.3 | 2.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.3 | 7.9 | GO:0097264 | self proteolysis(GO:0097264) |
1.3 | 1.3 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
1.3 | 6.5 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
1.3 | 3.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.3 | 10.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.3 | 1.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.3 | 2.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.3 | 3.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.3 | 3.9 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
1.3 | 3.9 | GO:0001927 | exocyst assembly(GO:0001927) |
1.3 | 1.3 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
1.3 | 1.3 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
1.3 | 3.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.3 | 23.3 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
1.3 | 5.2 | GO:0034331 | cell junction maintenance(GO:0034331) |
1.3 | 2.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.3 | 7.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.3 | 1.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.3 | 1.3 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
1.3 | 1.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.3 | 2.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.3 | 1.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.3 | 1.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
1.3 | 2.6 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.3 | 1.3 | GO:0006598 | polyamine catabolic process(GO:0006598) |
1.3 | 6.4 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.3 | 3.8 | GO:0031648 | protein destabilization(GO:0031648) |
1.3 | 3.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.3 | 3.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.3 | 58.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
1.3 | 2.5 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
1.3 | 11.4 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
1.3 | 3.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.3 | 8.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.3 | 6.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
1.3 | 1.3 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
1.3 | 1.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.3 | 3.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.3 | 5.0 | GO:0030091 | protein repair(GO:0030091) |
1.3 | 2.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.3 | 34.0 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
1.3 | 3.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.3 | 2.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.3 | 10.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
1.3 | 6.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.2 | 1.2 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
1.2 | 8.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
1.2 | 2.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.2 | 12.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
1.2 | 3.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.2 | 2.5 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.2 | 3.7 | GO:0015755 | fructose transport(GO:0015755) |
1.2 | 3.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
1.2 | 2.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.2 | 3.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.2 | 3.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.2 | 5.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.2 | 3.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.2 | 7.4 | GO:0030432 | peristalsis(GO:0030432) |
1.2 | 16.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.2 | 13.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
1.2 | 6.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.2 | 2.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.2 | 17.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.2 | 6.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.2 | 3.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.2 | 1.2 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.2 | 9.8 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
1.2 | 2.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.2 | 6.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.2 | 3.7 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.2 | 4.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.2 | 20.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
1.2 | 2.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.2 | 13.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
1.2 | 18.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
1.2 | 9.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.2 | 6.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.2 | 2.4 | GO:0015817 | histidine transport(GO:0015817) |
1.2 | 1.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
1.2 | 3.6 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
1.2 | 8.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
1.2 | 3.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
1.2 | 2.4 | GO:0016246 | RNA interference(GO:0016246) |
1.2 | 2.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.2 | 4.8 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
1.2 | 3.6 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
1.2 | 1.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.2 | 3.6 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
1.2 | 1.2 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
1.2 | 17.8 | GO:0007032 | endosome organization(GO:0007032) |
1.2 | 3.6 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.2 | 3.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.2 | 3.6 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
1.2 | 4.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.2 | 4.7 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.2 | 5.9 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
1.2 | 8.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
1.2 | 5.9 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
1.2 | 18.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.2 | 24.6 | GO:0035329 | hippo signaling(GO:0035329) |
1.2 | 2.3 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
1.2 | 4.7 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.2 | 16.4 | GO:0060074 | synapse maturation(GO:0060074) |
1.2 | 3.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.2 | 2.3 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.2 | 2.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.2 | 2.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
1.2 | 1.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.2 | 3.5 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
1.2 | 15.1 | GO:0006101 | citrate metabolic process(GO:0006101) |
1.2 | 8.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
1.2 | 3.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.2 | 2.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.2 | 3.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.2 | 1.2 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
1.2 | 4.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.2 | 28.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.2 | 4.6 | GO:0070528 | protein kinase C signaling(GO:0070528) |
1.2 | 6.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
1.2 | 2.3 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
1.2 | 5.8 | GO:0031103 | axon regeneration(GO:0031103) |
1.2 | 2.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
1.2 | 2.3 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
1.1 | 5.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.1 | 2.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.1 | 3.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.1 | 33.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
1.1 | 1.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.1 | 2.3 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.1 | 12.6 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
1.1 | 1.1 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
1.1 | 4.6 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
1.1 | 5.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
1.1 | 2.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
1.1 | 3.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
1.1 | 4.6 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.1 | 6.8 | GO:0015677 | copper ion import(GO:0015677) |
1.1 | 12.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.1 | 4.5 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
1.1 | 2.3 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.1 | 1.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
1.1 | 4.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.1 | 5.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.1 | 7.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
1.1 | 2.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.1 | 2.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
1.1 | 5.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.1 | 2.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.1 | 3.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.1 | 1.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.1 | 4.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.1 | 5.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.1 | 5.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.1 | 3.4 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.1 | 3.4 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
1.1 | 4.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
1.1 | 25.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
1.1 | 7.8 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.1 | 3.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.1 | 3.3 | GO:0019068 | virion assembly(GO:0019068) |
1.1 | 16.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.1 | 1.1 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
1.1 | 7.8 | GO:0043084 | penile erection(GO:0043084) |
1.1 | 7.7 | GO:0036065 | fucosylation(GO:0036065) |
1.1 | 19.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
1.1 | 3.3 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
1.1 | 7.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
1.1 | 18.7 | GO:0007031 | peroxisome organization(GO:0007031) |
1.1 | 9.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.1 | 13.2 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
1.1 | 11.0 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
1.1 | 3.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.1 | 3.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.1 | 1.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
1.1 | 15.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.1 | 2.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
1.1 | 6.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.1 | 3.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.1 | 7.6 | GO:0032328 | alanine transport(GO:0032328) |
1.1 | 5.5 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
1.1 | 2.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
1.1 | 3.3 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
1.1 | 3.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.1 | 1.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.1 | 4.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
1.1 | 15.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.1 | 2.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.1 | 11.9 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
1.1 | 2.2 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
1.1 | 1.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.1 | 3.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
1.1 | 5.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
1.1 | 4.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.1 | 4.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.1 | 2.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.1 | 1.1 | GO:0030035 | microspike assembly(GO:0030035) |
1.1 | 4.3 | GO:0010225 | response to UV-C(GO:0010225) |
1.1 | 1.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.1 | 3.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.1 | 7.5 | GO:0006465 | signal peptide processing(GO:0006465) |
1.1 | 1.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
1.1 | 1.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
1.1 | 3.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.1 | 4.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.1 | 2.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.1 | 1.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
1.1 | 5.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
1.1 | 1.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.1 | 8.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
1.1 | 2.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
1.1 | 5.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.1 | 2.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.1 | 1.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
1.1 | 13.8 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
1.1 | 5.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
1.1 | 2.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.1 | 12.7 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
1.1 | 2.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.1 | 5.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.1 | 3.2 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
1.1 | 3.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.1 | 9.5 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
1.1 | 1.1 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.1 | 2.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.0 | 7.3 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
1.0 | 34.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
1.0 | 12.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.0 | 27.2 | GO:1901998 | toxin transport(GO:1901998) |
1.0 | 1.0 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
1.0 | 3.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.0 | 19.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.0 | 3.1 | GO:0086009 | membrane repolarization(GO:0086009) |
1.0 | 1.0 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.0 | 3.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.0 | 1.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
1.0 | 4.2 | GO:0060004 | reflex(GO:0060004) |
1.0 | 10.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
1.0 | 11.4 | GO:0043248 | proteasome assembly(GO:0043248) |
1.0 | 2.1 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
1.0 | 1.0 | GO:0051340 | regulation of ligase activity(GO:0051340) |
1.0 | 21.7 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
1.0 | 1.0 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
1.0 | 6.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
1.0 | 3.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
1.0 | 3.1 | GO:0009650 | UV protection(GO:0009650) |
1.0 | 3.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
1.0 | 3.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.0 | 4.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
1.0 | 5.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.0 | 2.1 | GO:0010042 | response to manganese ion(GO:0010042) |
1.0 | 5.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
1.0 | 2.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.0 | 4.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.0 | 2.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
1.0 | 7.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.0 | 16.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.0 | 4.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.0 | 2.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
1.0 | 5.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.0 | 1.0 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
1.0 | 3.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.0 | 3.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.0 | 3.0 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.0 | 1.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.0 | 15.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.0 | 4.0 | GO:1902969 | mitotic DNA replication(GO:1902969) |
1.0 | 37.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
1.0 | 4.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
1.0 | 3.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.0 | 3.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
1.0 | 23.1 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
1.0 | 2.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.0 | 1.0 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
1.0 | 27.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
1.0 | 2.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.0 | 4.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.0 | 1.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
1.0 | 2.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.0 | 3.0 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
1.0 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
1.0 | 6.9 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
1.0 | 6.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.0 | 3.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
1.0 | 3.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.0 | 3.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.0 | 2.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.0 | 1.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.0 | 12.7 | GO:1903146 | regulation of mitophagy(GO:1903146) |
1.0 | 16.6 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
1.0 | 24.4 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
1.0 | 2.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.0 | 3.9 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
1.0 | 10.7 | GO:0016180 | snRNA processing(GO:0016180) |
1.0 | 3.9 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.0 | 1.9 | GO:0001842 | neural fold formation(GO:0001842) |
1.0 | 1.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
1.0 | 1.9 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
1.0 | 1.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.0 | 3.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
1.0 | 5.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
1.0 | 1.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.0 | 4.8 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
1.0 | 7.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
1.0 | 5.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.0 | 1.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.0 | 1.9 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
1.0 | 1.0 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
1.0 | 3.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.0 | 1.9 | GO:0060746 | parental behavior(GO:0060746) |
1.0 | 2.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.0 | 8.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.0 | 6.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.0 | 1.0 | GO:0032898 | neurotrophin production(GO:0032898) |
1.0 | 1.9 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.0 | 3.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.0 | 1.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.0 | 1.9 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.0 | 2.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.0 | 3.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.0 | 1.9 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
1.0 | 3.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.0 | 1.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.0 | 4.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.0 | 12.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
1.0 | 2.9 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
1.0 | 7.6 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
0.9 | 15.2 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.9 | 10.4 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.9 | 1.9 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.9 | 4.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.9 | 2.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.9 | 4.7 | GO:0016241 | regulation of macroautophagy(GO:0016241) regulation of vacuole organization(GO:0044088) |
0.9 | 2.8 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.9 | 31.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.9 | 4.7 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.9 | 9.4 | GO:0045056 | transcytosis(GO:0045056) |
0.9 | 1.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.9 | 5.6 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.9 | 0.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.9 | 13.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.9 | 9.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.9 | 0.9 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.9 | 7.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.9 | 4.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.9 | 4.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.9 | 17.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.9 | 3.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.9 | 8.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.9 | 0.9 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.9 | 0.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.9 | 4.6 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.9 | 5.5 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.9 | 0.9 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.9 | 4.6 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.9 | 5.5 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.9 | 3.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.9 | 15.6 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.9 | 7.3 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.9 | 2.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.9 | 5.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.9 | 0.9 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.9 | 2.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.9 | 1.8 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.9 | 1.8 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.9 | 0.9 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.9 | 1.8 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.9 | 1.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.9 | 0.9 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.9 | 2.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.9 | 2.7 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
0.9 | 2.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.9 | 2.7 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.9 | 3.6 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.9 | 2.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.9 | 17.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.9 | 0.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.9 | 1.8 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.9 | 1.8 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.9 | 7.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.9 | 1.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.9 | 2.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.9 | 6.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.9 | 3.6 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.9 | 7.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.9 | 32.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.9 | 2.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.9 | 10.6 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.9 | 1.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.9 | 8.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.9 | 1.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.9 | 1.8 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.9 | 3.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.9 | 0.9 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.9 | 0.9 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.9 | 2.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.9 | 7.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.9 | 2.6 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.9 | 3.5 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.9 | 7.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.9 | 0.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.9 | 2.6 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.9 | 1.8 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.9 | 6.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.9 | 1.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.9 | 13.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.9 | 1.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.9 | 4.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.9 | 17.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.9 | 1.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.9 | 8.7 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.9 | 5.2 | GO:0051181 | cofactor transport(GO:0051181) |
0.9 | 0.9 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.9 | 3.5 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.9 | 6.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.9 | 3.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.9 | 17.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.9 | 10.4 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.9 | 3.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.9 | 0.9 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.9 | 2.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.9 | 0.9 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.9 | 1.7 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.9 | 24.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.9 | 7.8 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.9 | 0.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.9 | 2.6 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.9 | 2.6 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.9 | 0.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.9 | 0.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.9 | 2.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.9 | 16.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.9 | 4.3 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.9 | 7.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.9 | 7.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.9 | 6.0 | GO:0042407 | cristae formation(GO:0042407) |
0.9 | 2.6 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.9 | 0.9 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.9 | 0.9 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.9 | 6.8 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.9 | 3.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.9 | 14.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.9 | 7.7 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.8 | 0.8 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.8 | 2.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.8 | 7.6 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.8 | 5.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.8 | 17.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.8 | 1.7 | GO:0043482 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.8 | 11.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.8 | 10.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.8 | 1.7 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.8 | 2.5 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.8 | 7.6 | GO:0097009 | energy homeostasis(GO:0097009) |
0.8 | 1.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.8 | 34.5 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.8 | 1.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.8 | 0.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.8 | 0.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.8 | 6.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.8 | 1.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.8 | 30.2 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.8 | 2.5 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.8 | 5.0 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.8 | 5.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.8 | 5.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.8 | 1.7 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.8 | 0.8 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.8 | 5.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.8 | 1.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.8 | 1.7 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.8 | 13.3 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.8 | 13.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.8 | 2.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.8 | 26.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.8 | 9.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.8 | 6.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.8 | 2.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.8 | 17.3 | GO:0022900 | electron transport chain(GO:0022900) |
0.8 | 1.6 | GO:0030576 | Cajal body organization(GO:0030576) |
0.8 | 7.4 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.8 | 28.0 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.8 | 0.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.8 | 1.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.8 | 2.5 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.8 | 2.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.8 | 3.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.8 | 1.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.8 | 2.4 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.8 | 3.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.8 | 3.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.8 | 1.6 | GO:0006983 | ER overload response(GO:0006983) |
0.8 | 1.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.8 | 6.5 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.8 | 3.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.8 | 3.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.8 | 2.4 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.8 | 2.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.8 | 0.8 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.8 | 3.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.8 | 2.4 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.8 | 2.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.8 | 0.8 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.8 | 2.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.8 | 0.8 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.8 | 1.6 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.8 | 2.4 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.8 | 3.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.8 | 7.1 | GO:0001964 | startle response(GO:0001964) |
0.8 | 4.0 | GO:0014047 | glutamate secretion(GO:0014047) |
0.8 | 3.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.8 | 0.8 | GO:0061081 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.8 | 9.5 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.8 | 11.1 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.8 | 2.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.8 | 7.9 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.8 | 0.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.8 | 16.5 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.8 | 9.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.8 | 3.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.8 | 2.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.8 | 1.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.8 | 17.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.8 | 3.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.8 | 3.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.8 | 2.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.8 | 2.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.8 | 3.9 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.8 | 2.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.8 | 6.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.8 | 7.7 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.8 | 9.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.8 | 4.6 | GO:0090329 | regulation of DNA-dependent DNA replication(GO:0090329) |
0.8 | 1.5 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.8 | 1.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.8 | 2.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.8 | 0.8 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.8 | 0.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.8 | 0.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.8 | 0.8 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.8 | 2.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.8 | 1.5 | GO:0045471 | response to ethanol(GO:0045471) |
0.8 | 3.8 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.8 | 3.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.8 | 8.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.8 | 2.3 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.8 | 0.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.8 | 0.8 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.8 | 1.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.8 | 13.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.8 | 2.3 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.8 | 5.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.8 | 4.5 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.7 | 0.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.7 | 9.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.7 | 3.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.7 | 1.5 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.7 | 3.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.7 | 1.5 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.7 | 6.0 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.7 | 3.0 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.7 | 2.2 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.7 | 0.7 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.7 | 2.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.7 | 12.6 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.7 | 12.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.7 | 2.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.7 | 7.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.7 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.7 | 5.2 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.7 | 2.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.7 | 0.7 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.7 | 3.7 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.7 | 1.5 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.7 | 0.7 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.7 | 2.9 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.7 | 3.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.7 | 5.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.7 | 0.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.7 | 0.7 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.7 | 4.4 | GO:1904355 | regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
0.7 | 5.8 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.7 | 20.4 | GO:0043038 | amino acid activation(GO:0043038) |
0.7 | 0.7 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.7 | 6.6 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.7 | 3.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.7 | 6.6 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.7 | 5.8 | GO:0019076 | viral release from host cell(GO:0019076) |
0.7 | 3.6 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.7 | 1.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.7 | 2.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.7 | 1.5 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.7 | 3.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.7 | 2.9 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.7 | 1.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.7 | 4.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.7 | 1.4 | GO:0042991 | transcription factor import into nucleus(GO:0042991) |
0.7 | 0.7 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.7 | 13.0 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.7 | 12.3 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.7 | 0.7 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.7 | 4.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.7 | 2.9 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.7 | 5.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.7 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
0.7 | 12.2 | GO:0009268 | response to pH(GO:0009268) |
0.7 | 5.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.7 | 40.9 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.7 | 1.4 | GO:0016577 | histone demethylation(GO:0016577) |
0.7 | 2.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.7 | 154.7 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.7 | 17.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.7 | 4.3 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.7 | 0.7 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.7 | 0.7 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.7 | 1.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.7 | 4.2 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.7 | 0.7 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.7 | 2.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.7 | 10.6 | GO:0014823 | response to activity(GO:0014823) |
0.7 | 3.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.7 | 3.5 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.7 | 10.5 | GO:0006414 | translational elongation(GO:0006414) |
0.7 | 4.2 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.7 | 3.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.7 | 13.3 | GO:0006476 | protein deacetylation(GO:0006476) |
0.7 | 7.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.7 | 18.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.7 | 0.7 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.7 | 1.4 | GO:0071711 | basement membrane organization(GO:0071711) |
0.7 | 3.5 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.7 | 5.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.7 | 0.7 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.7 | 1.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.7 | 2.8 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.7 | 6.9 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.7 | 1.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.7 | 13.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.7 | 0.7 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.7 | 9.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.7 | 10.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.7 | 7.6 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
0.7 | 10.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.7 | 2.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.7 | 2.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.7 | 17.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.7 | 2.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.7 | 5.4 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.7 | 7.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.7 | 0.7 | GO:0009642 | response to light intensity(GO:0009642) |
0.7 | 2.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.7 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.7 | 0.7 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.7 | 6.0 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.7 | 4.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.7 | 0.7 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.7 | 14.0 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.7 | 38.1 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.7 | 66.1 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.7 | 2.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.7 | 6.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.7 | 2.0 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.7 | 2.0 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.7 | 2.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.7 | 2.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.7 | 13.8 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.7 | 3.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.7 | 6.6 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.7 | 1.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.7 | 2.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.7 | 4.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.7 | 7.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.7 | 6.5 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.6 | 1.9 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.6 | 0.6 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.6 | 1.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.6 | 6.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.6 | 1.9 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.6 | 1.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.6 | 1.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.6 | 1.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.6 | 12.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.6 | 2.6 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.6 | 1.9 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.6 | 7.0 | GO:0007041 | lysosomal transport(GO:0007041) |
0.6 | 1.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.6 | 0.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.6 | 1.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) nucleoside salvage(GO:0043174) |
0.6 | 0.6 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.6 | 2.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.6 | 1.3 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) negative regulation by host of symbiont molecular function(GO:0052405) modulation by host of symbiont catalytic activity(GO:0052422) modification by host of symbiont molecular function(GO:0052428) |
0.6 | 3.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.6 | 1.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.6 | 8.7 | GO:0051225 | spindle assembly(GO:0051225) |
0.6 | 1.9 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.6 | 0.6 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.6 | 3.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.6 | 0.6 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) regulation of protein glycosylation in Golgi(GO:0090283) |
0.6 | 2.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.6 | 5.5 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.6 | 14.1 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.6 | 6.7 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.6 | 14.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.6 | 1.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.6 | 1.2 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.6 | 71.2 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.6 | 20.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.6 | 4.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.6 | 1.8 | GO:0006265 | DNA topological change(GO:0006265) |
0.6 | 1.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.6 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.6 | 4.2 | GO:0075733 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.6 | 9.0 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
0.6 | 1.8 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.6 | 5.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.6 | 0.6 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.6 | 23.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 2.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.6 | 0.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.6 | 3.0 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.6 | 1.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.6 | 3.6 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.6 | 4.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.6 | 2.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.6 | 1.8 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.6 | 2.4 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.6 | 15.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.6 | 1.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.6 | 0.6 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.6 | 1.8 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.6 | 7.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.6 | 1.8 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.6 | 7.6 | GO:0009408 | response to heat(GO:0009408) |
0.6 | 2.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 1.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.6 | 1.2 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.6 | 1.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.6 | 3.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.6 | 2.3 | GO:0051972 | regulation of telomerase activity(GO:0051972) positive regulation of telomerase activity(GO:0051973) |
0.6 | 1.1 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.6 | 0.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.6 | 0.6 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.6 | 0.6 | GO:1904429 | regulation of t-circle formation(GO:1904429) positive regulation of t-circle formation(GO:1904431) |
0.6 | 1.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.6 | 0.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.6 | 1.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 14.5 | GO:0006457 | protein folding(GO:0006457) |
0.6 | 2.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.6 | 0.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 1.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.6 | 6.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.5 | 0.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 3.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.5 | 1.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 1.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.5 | 1.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 0.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.5 | 2.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.5 | 0.5 | GO:2000407 | T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.5 | 1.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.5 | 0.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.5 | 3.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.5 | 2.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.5 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.5 | 0.5 | GO:0031649 | heat generation(GO:0031649) |
0.5 | 6.9 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.5 | 3.7 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.5 | 1.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 9.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 2.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.5 | 9.6 | GO:0016197 | endosomal transport(GO:0016197) |
0.5 | 6.4 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.5 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 34.9 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.5 | 0.5 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.5 | 3.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.5 | 2.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.5 | 0.5 | GO:0072665 | protein localization to endosome(GO:0036010) protein localization to vacuole(GO:0072665) |
0.5 | 3.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 1.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.5 | 3.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.5 | 1.6 | GO:0035640 | exploration behavior(GO:0035640) |
0.5 | 16.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.5 | 1.6 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.5 | 0.5 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.5 | 14.0 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.5 | 3.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.5 | 4.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.5 | 16.0 | GO:0000910 | cytokinesis(GO:0000910) |
0.5 | 0.5 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.5 | 2.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.5 | 0.5 | GO:0048512 | circadian behavior(GO:0048512) |
0.5 | 3.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.5 | 2.5 | GO:0045005 | replication fork processing(GO:0031297) DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.5 | 2.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.5 | 3.0 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.5 | 1.5 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.5 | 6.5 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.5 | 3.0 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.5 | 2.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 9.0 | GO:0019915 | lipid storage(GO:0019915) |
0.5 | 4.0 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.5 | 1.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 0.5 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.5 | 0.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.5 | 3.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.5 | 1.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 1.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.5 | 0.5 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.5 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 1.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.5 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 2.0 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.5 | 1.0 | GO:0007588 | excretion(GO:0007588) |
0.5 | 1.5 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.5 | 1.0 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.5 | 1.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 1.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.5 | 1.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.5 | 1.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.5 | 1.4 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.5 | 0.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.5 | 0.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.5 | 2.4 | GO:0032507 | maintenance of protein location in cell(GO:0032507) |
0.5 | 4.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.5 | 1.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 2.9 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.5 | 0.5 | GO:0070266 | necroptotic process(GO:0070266) |
0.5 | 3.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 3.8 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.5 | 1.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.5 | 2.8 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.5 | 4.2 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.5 | 2.4 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.5 | 1.4 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.5 | 0.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 0.5 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.5 | 1.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.5 | 0.5 | GO:0031033 | myosin filament organization(GO:0031033) |
0.5 | 2.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 0.9 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.5 | 1.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.5 | 2.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.5 | 1.9 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.5 | 0.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 3.2 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.5 | 0.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 5.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.5 | 14.7 | GO:0006364 | rRNA processing(GO:0006364) |
0.5 | 3.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 0.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.5 | 0.5 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.5 | 0.9 | GO:0097531 | mast cell migration(GO:0097531) |
0.5 | 1.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.5 | 1.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.5 | 0.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.4 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.4 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 0.9 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.4 | 1.8 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.4 | 4.5 | GO:0051297 | centrosome organization(GO:0051297) |
0.4 | 3.1 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.4 | 0.4 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.4 | 6.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.4 | 3.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.4 | 0.4 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.4 | 2.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.4 | 1.7 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.4 | 2.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 10.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.4 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.4 | 2.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 19.2 | GO:0098792 | xenophagy(GO:0098792) |
0.4 | 0.9 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.4 | 0.8 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.4 | 1.3 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.4 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 0.8 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.4 | 5.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.4 | 1.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.4 | 15.1 | GO:0006413 | translational initiation(GO:0006413) |
0.4 | 1.7 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.4 | 4.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.4 | 2.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.4 | 0.8 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.4 | 2.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 1.3 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.4 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 5.0 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.4 | 1.6 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) pteridine-containing compound biosynthetic process(GO:0042559) |
0.4 | 0.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 1.2 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.4 | 4.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.4 | 0.8 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.4 | 1.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 2.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 1.6 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.4 | 0.8 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.4 | 2.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.4 | 3.6 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.4 | 2.8 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.4 | 1.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.4 | 28.1 | GO:0042384 | cilium assembly(GO:0042384) |
0.4 | 0.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 0.8 | GO:0001508 | action potential(GO:0001508) |
0.4 | 16.0 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.4 | 0.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.4 | 2.4 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.4 | 0.4 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.4 | 1.6 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.4 | 0.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 0.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 0.4 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.4 | 0.8 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.4 | 1.6 | GO:0097576 | vacuole fusion(GO:0097576) |
0.4 | 13.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.4 | 0.8 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.4 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 0.4 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.4 | 0.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.4 | 0.4 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.4 | 1.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.4 | 1.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 2.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.4 | 1.1 | GO:0035090 | maintenance of cell polarity(GO:0030011) maintenance of apical/basal cell polarity(GO:0035090) |
0.4 | 0.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 2.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.4 | 1.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.4 | 0.7 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.4 | 1.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 1.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.4 | 10.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.4 | 5.5 | GO:0048017 | inositol lipid-mediated signaling(GO:0048017) |
0.4 | 4.8 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.4 | 11.7 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.4 | 5.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.4 | 0.4 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 0.4 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.4 | 0.4 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.4 | 0.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.4 | 0.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 0.7 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.4 | 1.8 | GO:0015992 | proton transport(GO:0015992) |
0.4 | 3.9 | GO:0030317 | sperm motility(GO:0030317) |
0.4 | 2.9 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.4 | 2.9 | GO:0032886 | regulation of microtubule-based process(GO:0032886) |
0.4 | 4.6 | GO:0042168 | heme metabolic process(GO:0042168) |
0.4 | 7.5 | GO:0006821 | chloride transport(GO:0006821) |
0.4 | 0.7 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.4 | 0.4 | GO:0001895 | retina homeostasis(GO:0001895) |
0.4 | 3.2 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.4 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.4 | 1.4 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.4 | 2.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.3 | 1.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 1.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 5.5 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) |
0.3 | 3.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 0.7 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.3 | 0.7 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.3 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 0.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 3.0 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.3 | 1.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 0.7 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.3 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 0.7 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 9.0 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.3 | 0.7 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.3 | 0.3 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.3 | 0.3 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
0.3 | 33.1 | GO:0030036 | actin cytoskeleton organization(GO:0030036) |
0.3 | 1.3 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 6.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.3 | 1.6 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.3 | 2.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.3 | 0.6 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 1.0 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.3 | 1.0 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 1.3 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.3 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 34.2 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.3 | 1.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 0.3 | GO:0045453 | bone resorption(GO:0045453) |
0.3 | 0.3 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.3 | 6.3 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.3 | 1.9 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.3 | 9.2 | GO:0018393 | internal peptidyl-lysine acetylation(GO:0018393) |
0.3 | 1.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.5 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.3 | 0.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 1.8 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.3 | 15.5 | GO:0010876 | lipid localization(GO:0010876) |
0.3 | 0.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 0.6 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 5.9 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.3 | 0.6 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.3 | 0.3 | GO:0002931 | response to ischemia(GO:0002931) |
0.3 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 0.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.9 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.3 | 2.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.3 | 2.6 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.3 | 0.6 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.3 | 2.3 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.3 | 2.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.3 | 0.6 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.3 | 4.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.3 | 0.3 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 0.6 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.3 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 1.1 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.3 | 4.4 | GO:0033674 | positive regulation of kinase activity(GO:0033674) |
0.3 | 1.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.3 | 1.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.3 | 0.3 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.3 | 4.3 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.3 | 1.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.3 | 0.8 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.3 | 6.3 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.3 | 0.8 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.3 | 0.5 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.3 | 3.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 1.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.3 | 0.5 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 2.5 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.3 | 4.6 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.3 | 0.3 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.3 | 6.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 3.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.3 | 5.0 | GO:0051924 | regulation of calcium ion transport(GO:0051924) |
0.2 | 5.3 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.2 | 1.0 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.2 | 0.5 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.2 | 2.4 | GO:0001666 | response to hypoxia(GO:0001666) |
0.2 | 3.6 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 0.5 | GO:0015791 | polyol transport(GO:0015791) renal water absorption(GO:0070295) |
0.2 | 10.2 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.2 | 1.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 1.2 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.2 | 1.4 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.7 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.2 | 0.5 | GO:0042637 | catagen(GO:0042637) |
0.2 | 1.8 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.2 | 1.6 | GO:0061025 | membrane fusion(GO:0061025) |
0.2 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 0.4 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.2 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.4 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
0.2 | 1.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 2.2 | GO:0016311 | dephosphorylation(GO:0016311) |
0.2 | 2.4 | GO:0051262 | protein tetramerization(GO:0051262) |
0.2 | 0.4 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.2 | 0.2 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 1.5 | GO:0050821 | protein stabilization(GO:0050821) |
0.2 | 0.2 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.2 | 0.4 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.2 | 1.6 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.2 | 0.6 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.8 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.2 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 1.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 1.3 | GO:0031960 | response to corticosteroid(GO:0031960) response to glucocorticoid(GO:0051384) |
0.2 | 3.7 | GO:0006814 | sodium ion transport(GO:0006814) |
0.2 | 1.1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 1.0 | GO:0051180 | vitamin transport(GO:0051180) |
0.2 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 1.5 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.2 | 4.9 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.2 | 0.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 14.3 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.2 | 0.2 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.2 | 0.6 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 4.2 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.2 | 0.9 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 1.6 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.2 | 0.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.2 | 1.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.2 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.7 | GO:0070613 | regulation of protein processing(GO:0070613) |
0.2 | 0.2 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.2 | 1.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.2 | 0.2 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.2 | 0.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 1.9 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.2 | 0.7 | GO:0072523 | purine-containing compound catabolic process(GO:0072523) |
0.2 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.2 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.2 | 0.3 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.2 | 0.3 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.2 | 0.5 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.2 | 0.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 0.2 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.2 | 0.2 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.2 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 0.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.3 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 0.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 2.4 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.2 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.2 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.2 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.2 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 1.7 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 0.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.1 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.1 | 0.3 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.1 | GO:1990089 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.1 | 0.4 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.3 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 1.0 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.1 | 0.4 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.4 | GO:0072527 | pyrimidine-containing compound metabolic process(GO:0072527) |
0.1 | 0.3 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.9 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.1 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.1 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.1 | 0.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.4 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.5 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.1 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.4 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.5 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.1 | 0.4 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
0.1 | 0.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.2 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.1 | 0.6 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.1 | 0.1 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.1 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.1 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.1 | GO:0042738 | biphenyl metabolic process(GO:0018879) exogenous drug catabolic process(GO:0042738) |
0.1 | 0.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 2.1 | GO:0009636 | response to toxic substance(GO:0009636) |
0.1 | 0.3 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 1.9 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 1.6 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.1 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 13.7 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.9 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.1 | 0.2 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.3 | GO:0009310 | amine catabolic process(GO:0009310) |
0.1 | 1.7 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.1 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.1 | 3.7 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.1 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.1 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.1 | 0.1 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
0.1 | 0.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.9 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.1 | GO:0009895 | negative regulation of catabolic process(GO:0009895) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 2.3 | GO:0006979 | response to oxidative stress(GO:0006979) |
0.1 | 0.1 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.1 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 1.4 | GO:0070085 | glycosylation(GO:0070085) |
0.1 | 3.2 | GO:0051604 | protein maturation(GO:0051604) |
0.1 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 1.4 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.1 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.2 | GO:0036230 | granulocyte activation(GO:0036230) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.1 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.1 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.0 | 0.1 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.6 | GO:0055074 | calcium ion homeostasis(GO:0055074) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.2 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.0 | 0.6 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.1 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.0 | 0.4 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.2 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.7 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.1 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.0 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.4 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.0 | 0.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 3.8 | GO:0055085 | transmembrane transport(GO:0055085) |
0.0 | 37.7 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.0 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.0 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.0 | GO:0002715 | regulation of natural killer cell mediated immunity(GO:0002715) |
0.0 | 0.0 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
0.0 | 0.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.0 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.0 | 0.0 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.0 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.0 | 0.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.0 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
4.2 | 29.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
3.9 | 11.7 | GO:0097513 | myosin II filament(GO:0097513) |
3.9 | 7.8 | GO:0071564 | npBAF complex(GO:0071564) |
3.8 | 11.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.7 | 11.0 | GO:0044393 | microspike(GO:0044393) |
3.5 | 10.5 | GO:0097443 | sorting endosome(GO:0097443) |
3.5 | 10.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
3.5 | 10.4 | GO:0031417 | NatC complex(GO:0031417) |
3.4 | 10.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
3.2 | 16.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
3.1 | 40.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
3.0 | 6.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
3.0 | 9.0 | GO:1990635 | proximal dendrite(GO:1990635) |
2.9 | 11.6 | GO:0072487 | MSL complex(GO:0072487) |
2.9 | 14.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.9 | 11.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
2.8 | 25.0 | GO:0097470 | ribbon synapse(GO:0097470) |
2.7 | 8.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
2.7 | 10.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
2.7 | 8.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
2.6 | 7.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
2.6 | 10.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
2.6 | 10.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.6 | 17.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
2.5 | 15.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.5 | 25.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
2.4 | 4.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
2.4 | 2.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
2.4 | 35.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
2.4 | 21.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
2.4 | 4.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
2.3 | 9.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.3 | 9.4 | GO:0071203 | WASH complex(GO:0071203) |
2.3 | 2.3 | GO:0016528 | sarcoplasm(GO:0016528) |
2.3 | 2.3 | GO:0000812 | Swr1 complex(GO:0000812) |
2.3 | 18.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
2.2 | 24.4 | GO:0043194 | axon initial segment(GO:0043194) |
2.1 | 15.0 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
2.1 | 22.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
2.1 | 8.3 | GO:0000805 | X chromosome(GO:0000805) |
2.1 | 18.6 | GO:0016342 | catenin complex(GO:0016342) |
2.1 | 6.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
2.0 | 6.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
2.0 | 6.1 | GO:0043293 | apoptosome(GO:0043293) |
2.0 | 8.2 | GO:0044308 | axonal spine(GO:0044308) |
2.0 | 2.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
2.0 | 6.1 | GO:0051286 | cell tip(GO:0051286) |
2.0 | 2.0 | GO:0032433 | filopodium tip(GO:0032433) |
2.0 | 6.0 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
2.0 | 10.0 | GO:0030870 | Mre11 complex(GO:0030870) |
2.0 | 31.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
2.0 | 2.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
1.9 | 5.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.9 | 5.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.9 | 11.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.9 | 11.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
1.9 | 17.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.9 | 3.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
1.9 | 7.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.9 | 35.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.8 | 11.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.8 | 7.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.8 | 3.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.8 | 14.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
1.8 | 12.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.8 | 3.6 | GO:0033263 | CORVET complex(GO:0033263) |
1.8 | 10.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.8 | 1.8 | GO:0000125 | PCAF complex(GO:0000125) |
1.8 | 3.6 | GO:0005840 | ribosome(GO:0005840) |
1.8 | 18.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.8 | 5.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.8 | 10.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.8 | 10.7 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
1.8 | 5.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.8 | 12.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.7 | 3.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.7 | 6.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
1.7 | 5.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.7 | 5.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.7 | 17.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.7 | 1.7 | GO:1903349 | omegasome membrane(GO:1903349) |
1.7 | 8.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.7 | 10.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.7 | 10.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.7 | 5.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.7 | 6.8 | GO:0030891 | VCB complex(GO:0030891) |
1.7 | 69.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.7 | 81.0 | GO:0043198 | dendritic shaft(GO:0043198) |
1.7 | 5.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.7 | 1.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.7 | 5.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.7 | 43.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.7 | 1.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.7 | 15.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.7 | 3.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.7 | 15.0 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.7 | 1.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.7 | 6.6 | GO:0071797 | LUBAC complex(GO:0071797) |
1.7 | 21.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.7 | 6.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.7 | 11.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.6 | 6.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.6 | 4.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.6 | 26.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.6 | 4.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.6 | 4.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.6 | 8.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.6 | 24.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.6 | 4.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.6 | 8.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.6 | 4.8 | GO:0036396 | MIS complex(GO:0036396) |
1.6 | 22.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.6 | 12.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.6 | 6.2 | GO:0045298 | tubulin complex(GO:0045298) |
1.5 | 12.4 | GO:0000124 | SAGA complex(GO:0000124) |
1.5 | 7.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.5 | 19.9 | GO:0030914 | STAGA complex(GO:0030914) |
1.5 | 22.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.5 | 9.1 | GO:0042587 | glycogen granule(GO:0042587) |
1.5 | 6.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.5 | 10.5 | GO:0016011 | dystroglycan complex(GO:0016011) |
1.5 | 12.1 | GO:0001650 | fibrillar center(GO:0001650) |
1.5 | 4.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.5 | 4.5 | GO:0043511 | inhibin complex(GO:0043511) |
1.5 | 13.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.5 | 1.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
1.5 | 4.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.5 | 4.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.5 | 5.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
1.5 | 4.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.5 | 16.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.4 | 1.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.4 | 34.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.4 | 9.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.4 | 4.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.4 | 4.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.4 | 5.6 | GO:0042583 | chromaffin granule(GO:0042583) |
1.4 | 4.2 | GO:0048179 | activin receptor complex(GO:0048179) |
1.4 | 7.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.4 | 2.8 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.4 | 4.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.4 | 19.5 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.4 | 37.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
1.4 | 9.7 | GO:0030008 | TRAPP complex(GO:0030008) |
1.4 | 65.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.4 | 5.5 | GO:0030689 | Noc complex(GO:0030689) |
1.4 | 4.1 | GO:0071942 | XPC complex(GO:0071942) |
1.4 | 6.8 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
1.4 | 2.7 | GO:0030478 | actin cap(GO:0030478) |
1.4 | 4.1 | GO:0032584 | growth cone membrane(GO:0032584) |
1.4 | 9.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.4 | 4.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.4 | 1.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.3 | 5.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.3 | 10.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.3 | 4.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.3 | 5.3 | GO:0071817 | MMXD complex(GO:0071817) |
1.3 | 17.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.3 | 2.7 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.3 | 25.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.3 | 1.3 | GO:0005594 | FACIT collagen trimer(GO:0005593) collagen type IX trimer(GO:0005594) |
1.3 | 6.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.3 | 10.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.3 | 10.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.3 | 5.3 | GO:0000235 | astral microtubule(GO:0000235) |
1.3 | 19.7 | GO:0043034 | costamere(GO:0043034) |
1.3 | 5.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.3 | 2.6 | GO:0005955 | calcineurin complex(GO:0005955) |
1.3 | 2.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.3 | 2.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.3 | 2.6 | GO:0030990 | intraciliary transport particle(GO:0030990) |
1.3 | 1.3 | GO:1990357 | terminal web(GO:1990357) |
1.3 | 6.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.3 | 19.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.3 | 8.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.3 | 44.3 | GO:0031201 | SNARE complex(GO:0031201) |
1.3 | 5.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.3 | 6.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.3 | 32.9 | GO:0044440 | endosomal part(GO:0044440) |
1.3 | 6.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
1.3 | 60.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
1.3 | 7.6 | GO:0034464 | BBSome(GO:0034464) |
1.3 | 3.8 | GO:0097427 | microtubule bundle(GO:0097427) |
1.3 | 25.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.3 | 3.8 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
1.3 | 17.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.3 | 6.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.2 | 1.2 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
1.2 | 6.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
1.2 | 3.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.2 | 11.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.2 | 16.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
1.2 | 1.2 | GO:0032590 | dendrite membrane(GO:0032590) |
1.2 | 1.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.2 | 66.0 | GO:0042641 | actomyosin(GO:0042641) |
1.2 | 11.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.2 | 2.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
1.2 | 6.1 | GO:0070695 | FHF complex(GO:0070695) |
1.2 | 3.6 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.2 | 4.8 | GO:0005827 | polar microtubule(GO:0005827) |
1.2 | 1.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.2 | 14.4 | GO:0000242 | pericentriolar material(GO:0000242) |
1.2 | 12.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.2 | 20.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.2 | 2.4 | GO:0033268 | node of Ranvier(GO:0033268) |
1.2 | 34.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.2 | 4.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.2 | 7.1 | GO:0031415 | NatA complex(GO:0031415) |
1.2 | 3.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.2 | 3.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.2 | 3.5 | GO:0001891 | phagocytic cup(GO:0001891) |
1.2 | 19.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.2 | 44.3 | GO:0005776 | autophagosome(GO:0005776) |
1.2 | 1.2 | GO:0097342 | ripoptosome(GO:0097342) |
1.1 | 3.4 | GO:0031527 | filopodium membrane(GO:0031527) |
1.1 | 11.5 | GO:0031082 | BLOC complex(GO:0031082) |
1.1 | 20.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.1 | 5.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
1.1 | 5.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.1 | 3.4 | GO:0033269 | internode region of axon(GO:0033269) |
1.1 | 2.3 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.1 | 7.9 | GO:0097449 | astrocyte projection(GO:0097449) |
1.1 | 47.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
1.1 | 52.7 | GO:0005795 | Golgi stack(GO:0005795) |
1.1 | 2.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
1.1 | 4.5 | GO:0070876 | SOSS complex(GO:0070876) |
1.1 | 3.4 | GO:0071565 | nBAF complex(GO:0071565) |
1.1 | 1.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.1 | 1.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
1.1 | 3.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.1 | 38.9 | GO:0016592 | mediator complex(GO:0016592) |
1.1 | 42.2 | GO:0045171 | intercellular bridge(GO:0045171) |
1.1 | 26.6 | GO:0030315 | T-tubule(GO:0030315) |
1.1 | 5.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.1 | 2.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.1 | 22.1 | GO:1990391 | DNA repair complex(GO:1990391) |
1.1 | 1.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.1 | 2.2 | GO:0010369 | chromocenter(GO:0010369) |
1.1 | 16.5 | GO:0030904 | retromer complex(GO:0030904) |
1.1 | 4.4 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
1.1 | 10.9 | GO:0005652 | nuclear lamina(GO:0005652) |
1.1 | 6.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.1 | 4.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.1 | 49.6 | GO:0042383 | sarcolemma(GO:0042383) |
1.1 | 36.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.1 | 6.4 | GO:0031209 | SCAR complex(GO:0031209) |
1.1 | 2.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.1 | 7.5 | GO:0034399 | nuclear periphery(GO:0034399) |
1.1 | 1.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 4.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.1 | 2.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.1 | 6.4 | GO:0030673 | axolemma(GO:0030673) |
1.1 | 7.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.1 | 11.7 | GO:0001527 | microfibril(GO:0001527) |
1.1 | 5.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.1 | 56.1 | GO:0055037 | recycling endosome(GO:0055037) |
1.0 | 54.5 | GO:0030027 | lamellipodium(GO:0030027) |
1.0 | 1.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.0 | 11.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.0 | 3.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.0 | 11.5 | GO:0002102 | podosome(GO:0002102) |
1.0 | 41.8 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
1.0 | 8.4 | GO:0005839 | proteasome core complex(GO:0005839) |
1.0 | 103.4 | GO:0005769 | early endosome(GO:0005769) |
1.0 | 4.2 | GO:0005796 | Golgi lumen(GO:0005796) |
1.0 | 10.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.0 | 1.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.0 | 2.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
1.0 | 7.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
1.0 | 6.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.0 | 8.3 | GO:0070652 | HAUS complex(GO:0070652) |
1.0 | 20.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.0 | 3.1 | GO:0030054 | cell junction(GO:0030054) |
1.0 | 10.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.0 | 11.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
1.0 | 3.1 | GO:0097433 | dense body(GO:0097433) |
1.0 | 13.3 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
1.0 | 5.1 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.0 | 7.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.0 | 14.2 | GO:0046930 | pore complex(GO:0046930) |
1.0 | 26.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.0 | 51.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.0 | 6.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
1.0 | 21.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.0 | 4.0 | GO:0070852 | cell body fiber(GO:0070852) |
1.0 | 119.3 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.0 | 4.0 | GO:0005915 | zonula adherens(GO:0005915) |
1.0 | 7.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.0 | 1.0 | GO:0097422 | tubular endosome(GO:0097422) |
1.0 | 88.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
1.0 | 6.8 | GO:0005869 | dynactin complex(GO:0005869) |
1.0 | 2.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.0 | 1.9 | GO:0016460 | myosin II complex(GO:0016460) |
1.0 | 4.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.0 | 3.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.0 | 239.2 | GO:0005912 | adherens junction(GO:0005912) |
1.0 | 1.0 | GO:0030120 | vesicle coat(GO:0030120) |
0.9 | 49.4 | GO:0016605 | PML body(GO:0016605) |
0.9 | 5.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.9 | 0.9 | GO:0005818 | aster(GO:0005818) |
0.9 | 1.9 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.9 | 6.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.9 | 1.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.9 | 5.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.9 | 0.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.9 | 4.7 | GO:0002177 | manchette(GO:0002177) |
0.9 | 7.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.9 | 3.7 | GO:0043205 | fibril(GO:0043205) |
0.9 | 7.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.9 | 2.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 4.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.9 | 12.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.9 | 9.2 | GO:0032039 | integrator complex(GO:0032039) |
0.9 | 8.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.9 | 7.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.9 | 1.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.9 | 2.7 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.9 | 20.8 | GO:0005901 | caveola(GO:0005901) |
0.9 | 15.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.9 | 0.9 | GO:1990351 | transporter complex(GO:1990351) |
0.9 | 21.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.9 | 1.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.9 | 37.6 | GO:0034705 | potassium channel complex(GO:0034705) |
0.9 | 1.8 | GO:0030684 | preribosome(GO:0030684) |
0.9 | 19.7 | GO:0030424 | axon(GO:0030424) |
0.9 | 38.4 | GO:0043197 | dendritic spine(GO:0043197) |
0.9 | 1.8 | GO:0012506 | vesicle membrane(GO:0012506) |
0.9 | 37.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.9 | 3.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.9 | 2.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.9 | 4.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.9 | 3.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.9 | 66.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.9 | 19.4 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.9 | 22.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.9 | 78.4 | GO:0097060 | synaptic membrane(GO:0097060) |
0.9 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
0.9 | 0.9 | GO:0089701 | U2AF(GO:0089701) |
0.9 | 25.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.9 | 1.7 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.9 | 1.7 | GO:0045180 | basal cortex(GO:0045180) |
0.9 | 2.6 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.9 | 0.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.9 | 13.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.9 | 1.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.9 | 4.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.9 | 2.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 30.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.9 | 6.8 | GO:0042555 | MCM complex(GO:0042555) |
0.9 | 2.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.8 | 69.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.8 | 18.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.8 | 72.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.8 | 2.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.8 | 0.8 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.8 | 2.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.8 | 21.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.8 | 1.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.8 | 4.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.8 | 3.3 | GO:0070938 | contractile ring(GO:0070938) |
0.8 | 2.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 5.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.8 | 3.3 | GO:0034709 | methylosome(GO:0034709) |
0.8 | 1.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.8 | 13.9 | GO:0030135 | coated vesicle(GO:0030135) |
0.8 | 15.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.8 | 14.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.8 | 5.7 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.8 | 7.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 5.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.8 | 8.8 | GO:0000145 | exocyst(GO:0000145) |
0.8 | 17.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.8 | 3.2 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.8 | 12.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.8 | 5.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.8 | 21.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.8 | 51.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.8 | 1.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.8 | 11.8 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.8 | 12.5 | GO:0015030 | Cajal body(GO:0015030) |
0.8 | 3.9 | GO:0000796 | condensin complex(GO:0000796) |
0.8 | 3.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.8 | 1.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.8 | 6.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.8 | 3.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.8 | 17.6 | GO:0005770 | late endosome(GO:0005770) |
0.8 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.8 | 9.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.8 | 1.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.8 | 3.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.8 | 4.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.8 | 2.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 15.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.7 | 1.5 | GO:1990923 | PET complex(GO:1990923) |
0.7 | 6.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.7 | 5.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.7 | 6.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.7 | 8.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.7 | 13.3 | GO:0005657 | replication fork(GO:0005657) |
0.7 | 78.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.7 | 10.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.7 | 201.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.7 | 88.4 | GO:0045202 | synapse(GO:0045202) |
0.7 | 2.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.7 | 439.3 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.7 | 5.7 | GO:0031672 | A band(GO:0031672) |
0.7 | 1.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.7 | 0.7 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 2.8 | GO:0070187 | telosome(GO:0070187) |
0.7 | 2.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.7 | 2.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.7 | 0.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.7 | 1.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.7 | 8.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.7 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.7 | 3.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.7 | 2.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.7 | 1.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.7 | 8.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.7 | 10.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.7 | 226.3 | GO:0005730 | nucleolus(GO:0005730) |
0.7 | 2.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.7 | 621.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.7 | 0.7 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.7 | 3.3 | GO:0042599 | lamellar body(GO:0042599) |
0.7 | 2.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.6 | 5.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.6 | 7.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.6 | 17.2 | GO:0005811 | lipid particle(GO:0005811) |
0.6 | 73.7 | GO:0005874 | microtubule(GO:0005874) |
0.6 | 3.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 5.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.6 | 2.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 8.1 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.6 | 4.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.6 | 3.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.6 | 1.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.6 | 10.4 | GO:0005844 | polysome(GO:0005844) |
0.6 | 2.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 24.3 | GO:0031514 | motile cilium(GO:0031514) |
0.6 | 5.5 | GO:0016604 | nuclear body(GO:0016604) |
0.6 | 1.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.6 | 6.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 1.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.6 | 8.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.6 | 71.0 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.6 | 33.6 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.6 | 13.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.6 | 13.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.6 | 33.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.6 | 2.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.6 | 37.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.6 | 1.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.6 | 6.4 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.6 | 58.8 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.6 | 1.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.6 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 2.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.6 | 1.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.6 | 1.7 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.6 | 31.8 | GO:0005604 | basement membrane(GO:0005604) |
0.6 | 3.9 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.6 | 229.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.5 | 274.8 | GO:0005829 | cytosol(GO:0005829) |
0.5 | 2.2 | GO:0030426 | growth cone(GO:0030426) |
0.5 | 23.8 | GO:0030016 | myofibril(GO:0030016) |
0.5 | 7.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.5 | 1.0 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 7.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.5 | 2.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 2.1 | GO:0045120 | pronucleus(GO:0045120) |
0.5 | 5.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.5 | 47.5 | GO:0005768 | endosome(GO:0005768) |
0.5 | 2.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 5.1 | GO:0030425 | dendrite(GO:0030425) |
0.5 | 5.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.5 | 26.6 | GO:0005929 | cilium(GO:0005929) |
0.5 | 7.2 | GO:0016459 | myosin complex(GO:0016459) |
0.5 | 1.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.5 | 2.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.5 | 2.8 | GO:0000801 | central element(GO:0000801) |
0.5 | 8.7 | GO:0031252 | cell leading edge(GO:0031252) |
0.5 | 389.9 | GO:0070062 | extracellular exosome(GO:0070062) |
0.5 | 82.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.4 | 0.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.4 | 1.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 0.4 | GO:0030496 | midbody(GO:0030496) |
0.4 | 20.9 | GO:0042995 | cell projection(GO:0042995) |
0.4 | 0.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 0.8 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.4 | 10.4 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.4 | 1.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 0.4 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.4 | 2.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 2.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.4 | 8.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.4 | 736.2 | GO:0005737 | cytoplasm(GO:0005737) |
0.4 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 18.6 | GO:0043235 | receptor complex(GO:0043235) |
0.4 | 3.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.3 | 5.9 | GO:0070160 | occluding junction(GO:0070160) |
0.3 | 6.3 | GO:0045177 | apical part of cell(GO:0045177) |
0.3 | 810.5 | GO:0016020 | membrane(GO:0016020) |
0.3 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 0.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) cohesin complex(GO:0008278) |
0.3 | 0.8 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.2 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 5.2 | GO:0009986 | cell surface(GO:0009986) |
0.2 | 34.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.3 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 82.3 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 1.1 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.2 | GO:0035859 | Seh1-associated complex(GO:0035859) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 6.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
6.0 | 18.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
5.5 | 16.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
5.1 | 15.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
4.6 | 22.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
4.5 | 13.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
4.5 | 9.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
4.0 | 12.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
4.0 | 12.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
4.0 | 19.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
3.9 | 3.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
3.8 | 11.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.4 | 16.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
3.4 | 10.1 | GO:2001070 | starch binding(GO:2001070) |
3.3 | 9.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
3.2 | 9.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
3.1 | 3.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
3.1 | 12.4 | GO:0036033 | mediator complex binding(GO:0036033) |
3.1 | 12.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
3.1 | 9.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
3.0 | 15.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
3.0 | 3.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
3.0 | 8.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.9 | 20.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.9 | 31.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
2.9 | 8.6 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
2.9 | 8.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
2.8 | 5.7 | GO:1990188 | euchromatin binding(GO:1990188) |
2.8 | 2.8 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
2.8 | 11.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.8 | 8.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
2.8 | 8.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.8 | 19.4 | GO:0045545 | syndecan binding(GO:0045545) |
2.8 | 13.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
2.7 | 8.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.7 | 21.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
2.7 | 8.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.7 | 24.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.7 | 8.1 | GO:0030371 | translation repressor activity(GO:0030371) |
2.7 | 8.0 | GO:0008142 | oxysterol binding(GO:0008142) |
2.7 | 16.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
2.6 | 2.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
2.6 | 7.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.6 | 10.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.6 | 7.9 | GO:0050692 | DBD domain binding(GO:0050692) |
2.6 | 7.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
2.6 | 7.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
2.5 | 17.3 | GO:0030957 | Tat protein binding(GO:0030957) |
2.5 | 4.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
2.5 | 7.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
2.5 | 9.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.4 | 7.3 | GO:0055100 | adiponectin binding(GO:0055100) |
2.4 | 12.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
2.4 | 9.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.4 | 2.4 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
2.4 | 14.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
2.4 | 2.4 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
2.4 | 12.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.4 | 7.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
2.4 | 52.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.4 | 9.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
2.4 | 7.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.4 | 7.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.4 | 7.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
2.4 | 11.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
2.3 | 7.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
2.3 | 11.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.3 | 9.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
2.3 | 6.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
2.3 | 11.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
2.3 | 9.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
2.3 | 2.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.3 | 6.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
2.3 | 9.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.3 | 2.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
2.3 | 11.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
2.3 | 18.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
2.3 | 4.5 | GO:0070538 | oleic acid binding(GO:0070538) |
2.2 | 2.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
2.2 | 8.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
2.2 | 2.2 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
2.2 | 6.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.2 | 19.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.2 | 6.6 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
2.2 | 8.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.2 | 10.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.2 | 2.2 | GO:0043398 | HLH domain binding(GO:0043398) |
2.2 | 6.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
2.2 | 8.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.2 | 8.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.2 | 2.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
2.2 | 6.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
2.1 | 8.6 | GO:0043559 | insulin binding(GO:0043559) |
2.1 | 6.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.1 | 8.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
2.1 | 6.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.1 | 6.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
2.1 | 14.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
2.0 | 12.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.0 | 14.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.0 | 6.1 | GO:0097016 | L27 domain binding(GO:0097016) |
2.0 | 8.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.0 | 2.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
2.0 | 6.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.0 | 10.0 | GO:0070728 | leucine binding(GO:0070728) |
2.0 | 2.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
2.0 | 5.9 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
2.0 | 3.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.0 | 2.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
2.0 | 5.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
2.0 | 21.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
2.0 | 5.9 | GO:0032142 | single guanine insertion binding(GO:0032142) |
1.9 | 1.9 | GO:0031420 | alkali metal ion binding(GO:0031420) |
1.9 | 7.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.9 | 7.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.9 | 5.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.9 | 32.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.9 | 7.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.9 | 34.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.9 | 24.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.9 | 5.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.9 | 30.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.9 | 5.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.9 | 7.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.9 | 15.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.9 | 22.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.9 | 1.9 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
1.9 | 5.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.9 | 9.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.9 | 24.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.9 | 14.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.9 | 44.7 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.9 | 5.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.9 | 18.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.9 | 50.1 | GO:0043531 | ADP binding(GO:0043531) |
1.9 | 9.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.8 | 3.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.8 | 7.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.8 | 18.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.8 | 22.1 | GO:0017166 | vinculin binding(GO:0017166) |
1.8 | 20.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.8 | 7.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.8 | 7.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.8 | 5.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.8 | 7.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.8 | 5.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.8 | 5.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.8 | 21.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.8 | 5.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.8 | 26.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.7 | 7.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
1.7 | 10.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.7 | 17.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.7 | 8.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.7 | 3.4 | GO:0030984 | kininogen binding(GO:0030984) |
1.7 | 18.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.7 | 5.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.7 | 17.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.7 | 1.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.7 | 11.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.7 | 1.7 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
1.7 | 3.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
1.7 | 6.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
1.7 | 6.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.7 | 8.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.7 | 10.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
1.7 | 13.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.7 | 3.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
1.7 | 30.4 | GO:0004629 | phospholipase C activity(GO:0004629) |
1.7 | 5.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
1.7 | 20.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.7 | 6.7 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.7 | 3.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.7 | 8.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.7 | 13.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.6 | 4.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
1.6 | 9.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.6 | 4.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.6 | 3.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.6 | 4.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.6 | 4.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.6 | 8.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.6 | 4.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.6 | 3.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.6 | 9.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.6 | 36.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.6 | 41.7 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
1.6 | 4.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.6 | 3.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.6 | 16.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.6 | 12.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.6 | 3.2 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
1.6 | 14.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.6 | 4.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.6 | 14.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.6 | 14.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.6 | 30.1 | GO:0030332 | cyclin binding(GO:0030332) |
1.6 | 9.5 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.6 | 3.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.6 | 1.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.6 | 1.6 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.6 | 6.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.6 | 1.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.6 | 9.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.6 | 1.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.5 | 4.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.5 | 7.7 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.5 | 29.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.5 | 1.5 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
1.5 | 3.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.5 | 4.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.5 | 36.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
1.5 | 4.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.5 | 16.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.5 | 9.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.5 | 10.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.5 | 4.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.5 | 18.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.5 | 4.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.5 | 6.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.5 | 9.0 | GO:0016595 | glutamate binding(GO:0016595) |
1.5 | 31.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.5 | 22.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.5 | 1.5 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
1.5 | 15.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.5 | 4.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.5 | 7.5 | GO:0004672 | protein kinase activity(GO:0004672) |
1.5 | 4.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.5 | 7.4 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
1.5 | 5.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.5 | 2.9 | GO:0016531 | copper chaperone activity(GO:0016531) superoxide dismutase copper chaperone activity(GO:0016532) |
1.5 | 2.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.5 | 4.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.5 | 1.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.5 | 1.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
1.5 | 1.5 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.5 | 2.9 | GO:0034979 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
1.5 | 2.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.5 | 14.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.5 | 4.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.4 | 8.7 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.4 | 4.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.4 | 47.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.4 | 2.9 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.4 | 11.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.4 | 4.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.4 | 4.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.4 | 2.9 | GO:2001069 | glycogen binding(GO:2001069) |
1.4 | 1.4 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.4 | 12.9 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.4 | 5.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
1.4 | 5.7 | GO:0005048 | signal sequence binding(GO:0005048) |
1.4 | 5.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.4 | 1.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.4 | 15.6 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
1.4 | 12.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.4 | 9.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.4 | 1.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.4 | 8.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
1.4 | 5.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.4 | 5.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.4 | 5.6 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.4 | 7.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.4 | 4.2 | GO:0089720 | caspase binding(GO:0089720) |
1.4 | 4.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.4 | 4.2 | GO:0042805 | actinin binding(GO:0042805) |
1.4 | 2.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.4 | 7.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.4 | 4.2 | GO:0016015 | morphogen activity(GO:0016015) |
1.4 | 4.2 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.4 | 2.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.4 | 4.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.4 | 7.0 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.4 | 5.6 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.4 | 7.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.4 | 11.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
1.4 | 29.0 | GO:0045296 | cadherin binding(GO:0045296) |
1.4 | 30.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
1.4 | 4.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.4 | 12.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.4 | 12.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.4 | 6.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.4 | 5.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.4 | 5.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.4 | 5.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.4 | 4.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.4 | 6.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.4 | 13.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
1.4 | 10.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.4 | 2.7 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.4 | 5.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.4 | 10.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.4 | 8.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
1.3 | 18.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.3 | 6.7 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
1.3 | 13.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.3 | 8.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.3 | 2.7 | GO:0097001 | ceramide binding(GO:0097001) |
1.3 | 10.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
1.3 | 4.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.3 | 25.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.3 | 14.7 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
1.3 | 4.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.3 | 41.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
1.3 | 9.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.3 | 61.9 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
1.3 | 2.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.3 | 7.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.3 | 6.5 | GO:0019894 | kinesin binding(GO:0019894) |
1.3 | 3.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.3 | 1.3 | GO:0003680 | AT DNA binding(GO:0003680) |
1.3 | 1.3 | GO:0034046 | poly(G) binding(GO:0034046) |
1.3 | 2.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.3 | 3.9 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.3 | 7.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.3 | 1.3 | GO:0016530 | metallochaperone activity(GO:0016530) |
1.3 | 3.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.3 | 38.2 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
1.3 | 17.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.3 | 11.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.3 | 26.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.3 | 5.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.3 | 15.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
1.3 | 6.3 | GO:0043426 | MRF binding(GO:0043426) |
1.3 | 2.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.3 | 10.0 | GO:0031386 | protein tag(GO:0031386) |
1.3 | 2.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.3 | 6.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.3 | 6.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.2 | 5.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.2 | 2.5 | GO:0071253 | connexin binding(GO:0071253) |
1.2 | 15.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.2 | 22.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.2 | 1.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.2 | 1.2 | GO:0005536 | glucose binding(GO:0005536) |
1.2 | 1.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
1.2 | 4.9 | GO:0009374 | biotin binding(GO:0009374) |
1.2 | 4.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.2 | 4.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.2 | 4.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.2 | 4.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
1.2 | 12.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
1.2 | 7.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
1.2 | 8.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.2 | 4.9 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
1.2 | 17.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.2 | 7.3 | GO:0031491 | nucleosome binding(GO:0031491) |
1.2 | 17.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.2 | 7.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.2 | 35.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.2 | 3.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.2 | 4.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.2 | 3.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.2 | 3.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.2 | 12.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
1.2 | 3.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.2 | 6.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.2 | 32.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.2 | 6.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.2 | 2.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
1.2 | 4.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.2 | 16.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.2 | 8.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.2 | 11.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.2 | 5.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.2 | 17.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.2 | 5.9 | GO:0000182 | rDNA binding(GO:0000182) |
1.2 | 3.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.2 | 3.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.2 | 8.2 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
1.2 | 23.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.2 | 4.7 | GO:0005522 | profilin binding(GO:0005522) |
1.2 | 8.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.2 | 23.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.2 | 24.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.2 | 7.0 | GO:0015288 | porin activity(GO:0015288) |
1.2 | 1.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
1.2 | 5.8 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
1.2 | 6.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
1.2 | 4.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.2 | 1.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.2 | 17.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
1.2 | 11.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.2 | 16.1 | GO:0005112 | Notch binding(GO:0005112) |
1.1 | 27.6 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
1.1 | 45.9 | GO:0035064 | methylated histone binding(GO:0035064) |
1.1 | 3.4 | GO:0035939 | microsatellite binding(GO:0035939) |
1.1 | 1.1 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
1.1 | 3.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.1 | 9.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.1 | 5.7 | GO:0030274 | LIM domain binding(GO:0030274) |
1.1 | 3.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.1 | 1.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.1 | 1.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.1 | 6.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.1 | 2.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.1 | 3.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.1 | 5.6 | GO:0031432 | titin binding(GO:0031432) |
1.1 | 3.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.1 | 36.1 | GO:0031072 | heat shock protein binding(GO:0031072) |
1.1 | 49.5 | GO:0019003 | GDP binding(GO:0019003) |
1.1 | 1.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.1 | 5.6 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.1 | 6.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.1 | 3.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.1 | 4.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.1 | 1.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.1 | 4.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.1 | 26.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.1 | 14.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.1 | 5.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.1 | 7.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.1 | 1.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.1 | 3.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.1 | 13.2 | GO:0005521 | lamin binding(GO:0005521) |
1.1 | 8.8 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
1.1 | 3.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.1 | 4.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.1 | 2.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.1 | 10.9 | GO:0070403 | NAD+ binding(GO:0070403) |
1.1 | 26.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.1 | 4.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.1 | 9.7 | GO:0005123 | death receptor binding(GO:0005123) |
1.1 | 7.6 | GO:0070628 | proteasome binding(GO:0070628) |
1.1 | 11.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
1.1 | 12.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.1 | 9.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
1.1 | 6.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.1 | 12.9 | GO:0031402 | sodium ion binding(GO:0031402) |
1.1 | 2.1 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
1.1 | 1.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
1.1 | 4.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.1 | 46.9 | GO:0008565 | protein transporter activity(GO:0008565) |
1.1 | 207.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
1.1 | 9.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.1 | 10.6 | GO:0051378 | serotonin binding(GO:0051378) |
1.1 | 1.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.1 | 4.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.1 | 2.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.1 | 6.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.1 | 16.9 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
1.1 | 3.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
1.1 | 32.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.0 | 22.0 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.0 | 2.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.0 | 3.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.0 | 21.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.0 | 3.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.0 | 20.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
1.0 | 2.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.0 | 4.1 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
1.0 | 4.1 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.0 | 16.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
1.0 | 4.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.0 | 1.0 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
1.0 | 16.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.0 | 3.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.0 | 3.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.0 | 19.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.0 | 7.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.0 | 1.0 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.0 | 2.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.0 | 4.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.0 | 1.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.0 | 7.1 | GO:0018640 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.0 | 9.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.0 | 4.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.0 | 2.0 | GO:0048038 | quinone binding(GO:0048038) |
1.0 | 21.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
1.0 | 4.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.0 | 12.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.0 | 6.0 | GO:0000339 | RNA cap binding(GO:0000339) |
1.0 | 32.1 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
1.0 | 3.0 | GO:0019961 | interferon binding(GO:0019961) |
1.0 | 17.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.0 | 1.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
1.0 | 1.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.0 | 2.0 | GO:0017040 | ceramidase activity(GO:0017040) |
1.0 | 19.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.0 | 5.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 3.0 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.0 | 4.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.0 | 6.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.0 | 1.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.0 | 18.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
1.0 | 24.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.0 | 2.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.0 | 2.0 | GO:0043176 | amine binding(GO:0043176) |
1.0 | 22.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.0 | 1.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.0 | 70.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
1.0 | 5.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.0 | 2.9 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.0 | 1.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.0 | 14.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
1.0 | 5.8 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
1.0 | 10.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
1.0 | 9.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.0 | 2.9 | GO:0043199 | sulfate binding(GO:0043199) |
1.0 | 11.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.9 | 8.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.9 | 2.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.9 | 31.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.9 | 2.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.9 | 3.8 | GO:0046790 | virion binding(GO:0046790) |
0.9 | 1.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.9 | 9.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.9 | 12.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.9 | 1.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.9 | 11.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.9 | 2.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.9 | 9.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.9 | 26.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.9 | 0.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.9 | 2.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.9 | 4.6 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.9 | 3.7 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.9 | 2.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.9 | 0.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.9 | 29.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.9 | 2.7 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.9 | 23.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.9 | 1.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.9 | 1.8 | GO:0048156 | tau protein binding(GO:0048156) |
0.9 | 5.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.9 | 5.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.9 | 4.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.9 | 0.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.9 | 27.1 | GO:0043621 | protein self-association(GO:0043621) |
0.9 | 7.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.9 | 3.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.9 | 13.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.9 | 5.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.9 | 0.9 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.9 | 4.5 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.9 | 33.8 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.9 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.9 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.9 | 2.7 | GO:0004096 | catalase activity(GO:0004096) |
0.9 | 16.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.9 | 2.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.9 | 11.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.9 | 5.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.9 | 2.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.9 | 3.5 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.9 | 0.9 | GO:0004359 | glutaminase activity(GO:0004359) |
0.9 | 3.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.9 | 13.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.9 | 1.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.9 | 2.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.9 | 1.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.9 | 1.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.9 | 8.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.9 | 14.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.9 | 6.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.9 | 40.4 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.9 | 2.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.9 | 2.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.9 | 4.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.9 | 0.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.9 | 3.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.9 | 1.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.9 | 1.7 | GO:0070513 | death domain binding(GO:0070513) |
0.8 | 6.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.8 | 29.6 | GO:0016247 | channel regulator activity(GO:0016247) |
0.8 | 30.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.8 | 0.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.8 | 11.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.8 | 35.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.8 | 4.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.8 | 2.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.8 | 15.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.8 | 2.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.8 | 1.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.8 | 12.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.8 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.8 | 5.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.8 | 2.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.8 | 3.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.8 | 9.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.8 | 4.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.8 | 4.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.8 | 1.6 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.8 | 4.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 4.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.8 | 3.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.8 | 10.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.8 | 1.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.8 | 7.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.8 | 16.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.8 | 4.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.8 | 4.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.8 | 75.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.8 | 27.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.8 | 4.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.8 | 2.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.8 | 7.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.8 | 4.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.8 | 1.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.8 | 1.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.8 | 0.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.8 | 2.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 23.7 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.8 | 41.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.8 | 4.7 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.8 | 40.9 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.8 | 5.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.8 | 0.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.8 | 2.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.8 | 1.6 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.8 | 6.3 | GO:0034868 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.8 | 2.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.8 | 3.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.8 | 3.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.8 | 1.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.8 | 1.5 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.8 | 3.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 33.8 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.8 | 2.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.8 | 12.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.8 | 2.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.8 | 21.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.8 | 3.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.8 | 6.1 | GO:0034876 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.8 | 2.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 5.3 | GO:0020037 | heme binding(GO:0020037) |
0.8 | 2.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 6.8 | GO:0016462 | pyrophosphatase activity(GO:0016462) |
0.8 | 3.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.8 | 151.2 | GO:0005525 | GTP binding(GO:0005525) |
0.8 | 2.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.8 | 2.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.8 | 2.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.8 | 2.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 3.0 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.7 | 11.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.7 | 40.6 | GO:0060090 | binding, bridging(GO:0060090) |
0.7 | 2.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.7 | 2.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.7 | 32.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.7 | 1.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.7 | 3.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.7 | 5.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.7 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.7 | 7.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.7 | 1.4 | GO:0016817 | hydrolase activity, acting on acid anhydrides(GO:0016817) |
0.7 | 27.4 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.7 | 17.3 | GO:0051287 | NAD binding(GO:0051287) |
0.7 | 4.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.7 | 12.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.7 | 0.7 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.7 | 0.7 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.7 | 7.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.7 | 4.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.7 | 17.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.7 | 5.0 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.7 | 2.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.7 | 7.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.7 | 2.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.7 | 16.2 | GO:0051020 | GTPase binding(GO:0051020) |
0.7 | 15.5 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.7 | 2.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.7 | 2.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.7 | 5.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.7 | 1.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.7 | 0.7 | GO:0019213 | deacetylase activity(GO:0019213) |
0.7 | 15.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.7 | 58.1 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.7 | 2.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.7 | 17.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.7 | 12.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.7 | 3.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.7 | 80.4 | GO:0015631 | tubulin binding(GO:0015631) |
0.7 | 4.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.7 | 25.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.7 | 6.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.7 | 11.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.7 | 4.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.7 | 5.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.7 | 4.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.7 | 3.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.7 | 3.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.7 | 2.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.7 | 1.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.7 | 4.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.7 | 0.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.7 | 11.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.7 | 3.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.7 | 0.7 | GO:0051373 | FATZ binding(GO:0051373) |
0.7 | 26.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.7 | 170.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.7 | 2.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.7 | 15.0 | GO:0005516 | calmodulin binding(GO:0005516) |
0.7 | 1.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.6 | 5.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.6 | 5.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.6 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 1.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.6 | 14.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.6 | 1.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.6 | 19.8 | GO:0005518 | collagen binding(GO:0005518) |
0.6 | 1.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.6 | 7.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.6 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 3.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.6 | 22.7 | GO:0042393 | histone binding(GO:0042393) |
0.6 | 12.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.6 | 1.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.6 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.6 | 3.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.6 | 5.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.6 | 5.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.6 | 48.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.6 | 43.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.6 | 16.7 | GO:0044325 | ion channel binding(GO:0044325) |
0.6 | 15.5 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.6 | 2.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 1.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 1.2 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.6 | 4.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.6 | 7.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.6 | 3.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.6 | 1.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 2.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.6 | 5.4 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.6 | 1.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.6 | 2.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.6 | 2.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.6 | 3.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.6 | 17.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.6 | 17.4 | GO:0042562 | hormone binding(GO:0042562) |
0.6 | 6.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.6 | 1.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 3.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.6 | 98.5 | GO:0003779 | actin binding(GO:0003779) |
0.6 | 0.6 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.6 | 2.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 36.8 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.6 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.6 | 2.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.6 | 8.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 2.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.6 | 24.0 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.6 | 79.0 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.6 | 17.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.6 | 17.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.6 | 7.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.6 | 1.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.6 | 2.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.5 | 2.7 | GO:0016301 | kinase activity(GO:0016301) |
0.5 | 1.6 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.5 | 7.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.5 | 4.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.5 | 3.8 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.5 | 3.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.5 | 16.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.5 | 14.6 | GO:0009055 | electron carrier activity(GO:0009055) |
0.5 | 4.8 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.5 | 1.1 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.5 | 25.2 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.5 | 1.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.5 | 16.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.5 | 2.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.5 | 8.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 3.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 11.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.5 | 4.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.5 | 3.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 2.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 4.2 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.5 | 2.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 1.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.5 | 1.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 1.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.5 | 3.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.5 | 77.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.5 | 6.7 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.5 | 9.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 0.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 4.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 14.8 | GO:0003774 | motor activity(GO:0003774) |
0.5 | 2.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.5 | 1.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.5 | 2.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.5 | 1.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.5 | 2.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 3.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.5 | 4.9 | GO:0019207 | kinase regulator activity(GO:0019207) |
0.5 | 2.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.5 | 225.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.5 | 2.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.5 | 0.5 | GO:0002054 | nucleobase binding(GO:0002054) |
0.5 | 6.8 | GO:0004871 | signal transducer activity(GO:0004871) |
0.5 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 8.5 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.5 | 8.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.5 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.5 | 0.5 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.5 | 1.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.5 | 34.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.5 | 13.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.5 | 0.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.5 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.5 | 2.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.5 | 0.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.5 | 6.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 0.4 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.4 | 15.6 | GO:0005496 | steroid binding(GO:0005496) |
0.4 | 4.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.4 | 3.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.4 | 0.9 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 3.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.4 | 1.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 3.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.4 | 1.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 1.7 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.4 | 0.8 | GO:0034934 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.4 | 0.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 2.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.4 | 0.8 | GO:0019103 | uridine nucleotide receptor activity(GO:0015065) pyrimidine nucleotide binding(GO:0019103) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.4 | 1.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.4 | 3.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 2.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 3.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.4 | 0.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.4 | 1.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 6.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 1.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.4 | 1.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.4 | 23.2 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.4 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 0.8 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.4 | 1.5 | GO:0015926 | glucosidase activity(GO:0015926) |
0.4 | 0.8 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 0.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 1.1 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.4 | 6.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 3.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 17.8 | GO:0019901 | protein kinase binding(GO:0019901) |
0.4 | 3.6 | GO:0034831 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) isocitrate dehydrogenase activity(GO:0004448) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.4 | 6.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.4 | 6.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.4 | 1.4 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 0.7 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 2.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 3.5 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.3 | 20.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.3 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 79.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.3 | 0.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 8.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 3.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 2.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 1.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 0.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.3 | 1.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 1.0 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 0.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 1.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 3.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 7.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 0.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 45.1 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.3 | 4.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 0.6 | GO:0016722 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions(GO:0016722) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 1.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.3 | 2.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 3.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 2.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 1.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.3 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 14.6 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.3 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 0.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 2.3 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.3 | 3.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 2.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 5.5 | GO:0008144 | drug binding(GO:0008144) |
0.3 | 1.6 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.3 | 18.2 | GO:0003723 | RNA binding(GO:0003723) |
0.3 | 1.6 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.3 | 0.3 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) bisphosphoglycerate phosphatase activity(GO:0034416) |
0.3 | 1.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 0.5 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.3 | 0.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.3 | 1.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 5.0 | GO:0016874 | ligase activity(GO:0016874) |
0.2 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 8.6 | GO:0018726 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.2 | 4.6 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.2 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 2.6 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 0.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 2.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 8.6 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.2 | 0.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.5 | GO:0016714 | phenylalanine 4-monooxygenase activity(GO:0004505) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 0.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 0.6 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 1.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.2 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.2 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 1.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.5 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 2.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 1.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 3.0 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 5.2 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 0.8 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.2 | 0.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.5 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 42.0 | GO:0042802 | identical protein binding(GO:0042802) |
0.2 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 4.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.2 | 7.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 12.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 1.6 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 37.1 | GO:0000166 | nucleotide binding(GO:0000166) nucleoside phosphate binding(GO:1901265) |
0.1 | 2.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 1.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 2.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 1.8 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 3.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 2.7 | GO:0016491 | oxidoreductase activity(GO:0016491) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 2.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 1.9 | GO:0015293 | symporter activity(GO:0015293) |
0.1 | 98.3 | GO:0046872 | metal ion binding(GO:0046872) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.6 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 3.5 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.1 | 2.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.1 | 0.5 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 1.0 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.1 | 0.8 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.2 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
0.1 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 37.3 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.1 | GO:0016841 | carbon-nitrogen lyase activity(GO:0016840) ammonia-lyase activity(GO:0016841) |
0.1 | 0.1 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.1 | 2.7 | GO:0042277 | peptide binding(GO:0042277) |
0.1 | 0.4 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.1 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0015922 | D-amino-acid oxidase activity(GO:0003884) aspartate oxidase activity(GO:0015922) D-lysine oxidase activity(GO:0043912) |
0.1 | 1.0 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.4 | GO:0015103 | inorganic anion transmembrane transporter activity(GO:0015103) |
0.1 | 1.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 68.7 | GO:0005515 | protein binding(GO:0005515) |
0.0 | 5.2 | GO:0003824 | catalytic activity(GO:0003824) |
0.0 | 0.2 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.0 | GO:0097367 | carbohydrate derivative binding(GO:0097367) |
0.0 | 0.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 19.4 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.6 | GO:0003682 | chromatin binding(GO:0003682) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 36.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
2.2 | 33.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
2.2 | 24.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
2.1 | 19.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
2.1 | 8.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.8 | 62.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.8 | 21.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.7 | 64.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.7 | 31.0 | PID REELIN PATHWAY | Reelin signaling pathway |
1.7 | 64.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.7 | 48.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.7 | 33.7 | PID RAS PATHWAY | Regulation of Ras family activation |
1.7 | 45.0 | PID INSULIN PATHWAY | Insulin Pathway |
1.7 | 13.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.7 | 21.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.6 | 68.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.6 | 66.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.6 | 16.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.6 | 37.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.6 | 12.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.5 | 16.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.5 | 4.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.5 | 11.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.5 | 8.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.5 | 3.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.5 | 30.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.5 | 19.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.5 | 8.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.5 | 26.3 | PID ARF 3PATHWAY | Arf1 pathway |
1.4 | 15.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.4 | 26.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.4 | 4.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.4 | 20.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.4 | 5.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.4 | 24.3 | PID MYC PATHWAY | C-MYC pathway |
1.3 | 28.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.3 | 9.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.3 | 11.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.3 | 6.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.3 | 2.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.3 | 27.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.3 | 3.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.2 | 8.7 | PID IFNG PATHWAY | IFN-gamma pathway |
1.2 | 34.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.2 | 27.1 | PID BARD1 PATHWAY | BARD1 signaling events |
1.2 | 6.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.2 | 8.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.2 | 11.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.2 | 23.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.2 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.2 | 29.1 | PID LKB1 PATHWAY | LKB1 signaling events |
1.2 | 12.7 | PID P73PATHWAY | p73 transcription factor network |
1.2 | 4.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.2 | 9.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.1 | 9.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.1 | 6.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.1 | 16.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.1 | 4.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.1 | 20.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.1 | 12.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.1 | 5.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.1 | 13.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.1 | 4.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.1 | 32.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.1 | 11.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.1 | 11.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.1 | 38.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.1 | 9.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.0 | 31.2 | PID PLK1 PATHWAY | PLK1 signaling events |
1.0 | 6.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.0 | 30.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.0 | 4.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.0 | 6.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.0 | 10.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.0 | 30.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.0 | 16.2 | PID FOXO PATHWAY | FoxO family signaling |
1.0 | 6.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.0 | 17.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.0 | 14.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.0 | 2.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.0 | 3.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.0 | 6.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.0 | 6.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.0 | 8.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.0 | 8.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.9 | 3.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.9 | 15.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.9 | 30.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.9 | 5.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.9 | 6.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.9 | 4.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.9 | 7.9 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.9 | 10.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.9 | 4.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.8 | 24.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.8 | 11.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.8 | 24.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.8 | 5.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.8 | 12.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 13.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.8 | 15.6 | PID ATR PATHWAY | ATR signaling pathway |
0.8 | 4.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.8 | 7.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.8 | 13.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 4.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 3.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.8 | 11.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.8 | 6.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.8 | 16.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.7 | 1.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.7 | 6.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.7 | 27.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.7 | 5.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.7 | 1.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.7 | 7.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.7 | 2.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.7 | 10.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.7 | 92.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.7 | 5.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.7 | 2.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.7 | 8.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.7 | 2.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.7 | 27.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.7 | 11.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.6 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
0.6 | 3.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.6 | 2.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.6 | 8.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.6 | 1.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.6 | 12.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.6 | 5.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 4.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 7.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.6 | 7.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 9.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.5 | 10.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.5 | 7.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.5 | 1.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 4.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 10.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 94.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 12.6 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 63.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 1.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.5 | 1.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.4 | 5.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 17.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 1.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 2.7 | PID ATM PATHWAY | ATM pathway |
0.3 | 2.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 0.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 1.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 3.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 1.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 1.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 4.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 2.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 34.8 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.6 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 3.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 4.1 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
4.0 | 4.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
3.2 | 15.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.9 | 2.9 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
2.7 | 2.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
2.6 | 86.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
2.6 | 25.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
2.5 | 5.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
2.5 | 4.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.5 | 7.4 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
2.4 | 19.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
2.4 | 19.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
2.4 | 26.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
2.3 | 14.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
2.3 | 30.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
2.2 | 33.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.2 | 17.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
2.2 | 28.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
2.2 | 6.6 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
2.2 | 17.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
2.2 | 23.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
2.1 | 23.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
2.1 | 19.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
2.1 | 25.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
2.0 | 24.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
2.0 | 17.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
2.0 | 21.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.0 | 23.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
1.9 | 29.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.9 | 42.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.9 | 17.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.9 | 3.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.9 | 13.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.9 | 24.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.9 | 3.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.9 | 9.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.9 | 7.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.8 | 16.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.8 | 41.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.8 | 12.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.8 | 19.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.8 | 23.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.7 | 12.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.7 | 29.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.7 | 22.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.7 | 20.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.7 | 21.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
1.7 | 23.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.7 | 1.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.6 | 42.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.6 | 9.9 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
1.6 | 19.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.6 | 15.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.6 | 50.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.6 | 1.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.6 | 12.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.5 | 28.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.5 | 28.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.5 | 14.7 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
1.5 | 10.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.4 | 40.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
1.4 | 25.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.4 | 9.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.4 | 23.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.4 | 8.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
1.4 | 19.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.4 | 4.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.4 | 14.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.3 | 16.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.3 | 18.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.3 | 9.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.3 | 13.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.3 | 14.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.3 | 17.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.3 | 6.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.3 | 24.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
1.3 | 2.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.3 | 28.7 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
1.3 | 14.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.3 | 23.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.3 | 17.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.3 | 14.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.3 | 14.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.3 | 16.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.3 | 15.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.3 | 11.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
1.3 | 8.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.2 | 11.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.2 | 8.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.2 | 3.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
1.2 | 18.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.2 | 66.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.2 | 26.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.2 | 31.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.2 | 23.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.2 | 43.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.2 | 21.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.2 | 3.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.2 | 12.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.2 | 1.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.2 | 10.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.2 | 46.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.2 | 2.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
1.2 | 11.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.1 | 2.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.1 | 17.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.1 | 20.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
1.1 | 1.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.1 | 6.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.1 | 5.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.1 | 17.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.1 | 3.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.1 | 2.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.1 | 6.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.1 | 5.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.1 | 4.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.1 | 3.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.1 | 12.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
1.1 | 3.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.1 | 9.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.1 | 13.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.1 | 13.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.1 | 22.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
1.1 | 6.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.1 | 25.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
1.1 | 4.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
1.1 | 5.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.1 | 17.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
1.1 | 12.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.1 | 23.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
1.1 | 6.4 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
1.1 | 13.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
1.0 | 8.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.0 | 47.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.0 | 6.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
1.0 | 39.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
1.0 | 115.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.0 | 20.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.0 | 13.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.0 | 20.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
1.0 | 2.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.0 | 9.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.0 | 5.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.0 | 3.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
1.0 | 8.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.0 | 5.9 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
1.0 | 18.6 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
1.0 | 5.8 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
1.0 | 5.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.0 | 6.8 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.0 | 5.8 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
1.0 | 9.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.0 | 20.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.0 | 23.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.9 | 3.7 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.9 | 14.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.9 | 14.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.9 | 5.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.9 | 2.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.9 | 2.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.9 | 11.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.9 | 49.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.9 | 7.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.9 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.9 | 4.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.9 | 7.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.9 | 8.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.9 | 9.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.9 | 1.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.9 | 21.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.9 | 14.6 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.9 | 63.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.8 | 16.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.8 | 36.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.8 | 11.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.8 | 3.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.8 | 10.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.8 | 40.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.8 | 0.8 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.8 | 15.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.8 | 8.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.8 | 27.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.8 | 5.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.8 | 13.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.8 | 2.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.8 | 2.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.8 | 3.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.8 | 5.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.8 | 8.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.8 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.8 | 13.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.8 | 2.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.8 | 3.0 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.8 | 26.4 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.8 | 10.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.8 | 30.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.7 | 64.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.7 | 8.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 5.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.7 | 23.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.7 | 3.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.7 | 26.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.7 | 6.3 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.7 | 3.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.7 | 4.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.7 | 14.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.7 | 63.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.7 | 4.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.7 | 9.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 2.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.7 | 4.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.7 | 5.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.6 | 0.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.6 | 1.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.6 | 20.6 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.6 | 3.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 11.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.6 | 6.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.6 | 3.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.6 | 6.9 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.6 | 20.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 12.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 14.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.6 | 2.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 5.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.6 | 19.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 4.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.5 | 8.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.5 | 3.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.5 | 4.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.5 | 13.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 5.8 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.5 | 3.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.5 | 4.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 1.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 3.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.5 | 37.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.5 | 0.9 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.5 | 2.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.5 | 8.8 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.5 | 0.5 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.5 | 12.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.5 | 7.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 6.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 33.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.4 | 4.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 2.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 1.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 10.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 4.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 3.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 6.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 14.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 5.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 2.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 1.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 0.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.3 | 3.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 1.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 0.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 20.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 4.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 8.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 3.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 72.7 | REACTOME GPCR DOWNSTREAM SIGNALING | Genes involved in GPCR downstream signaling |
0.3 | 0.6 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.3 | 1.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.7 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.2 | 0.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 0.9 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 9.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.2 | 0.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 3.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 0.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 1.6 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.2 | 1.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 8.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 1.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 2.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 5.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 1.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 3.1 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.1 | 0.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 0.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.1 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.1 | 1.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.9 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |